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Abstract 
 
X Chromosome Inactivation appeared as a mechanism to overcome gene dosage 
imbalance between males and females. The emergence of sex chromosomes and the 
continuous loss of genes by the Y during evolution created a situation where many X-
linked genes are now present in one copy in the male genome and in two copies in the 
female genome. The solution that mammals found was to inactivate the extra X in the 
females. This inactivation is paternally imprinted in marsupials. Mice show the two 
forms of XCI: initially imprinted at the four cells stage, then in the embryo proper 
reactivation occurs followed by a new wave of random inactivation, while the imprinted 
form is maintained in the trophoblast, so in the extra-embryonic tissues of the mouse 
the inactivated X is always the paternal one. If the imprinted form also occurs in humans 
as been an intense debate among researchers, with contradictory results in several 
reports. Here, we analyzed several extra-embryonic tissues from different human 
samples from the first trimester of development using HUMARA assay and parental 
specific transcription analysis and the results pointed to a random inactivation at the 
stages analyzed. The inactivation process, in mice, starts at the Xic (X inactivation 
center) where the Xist transcripts spread in cis from their site of synthesis to coat the 
entire chromosome. The coating starts in this spot and then progressively covers the 
entire chromosome, being the genes closer to Xic the ones to be inactivated first. Again, 
little is known about this dynamics in humans. The use of hES cell lines is of high interest 
as these cells recapitulate XCI in vitro if initially XaXa. Studying the expression levels of 
several X-linked chromosomes during hESC differentiation can give us some insights 
about this kinetic, and on the other hand, the state of XCI can help evaluate the 
pluripotency state of the lines. We used two hESC lines, a male and female, on D0 and 
D7 of differentiation to access XCI and pluripotency. The results suggested that the cells 
after D7 were not completely differentiated or that they might be initially at a semi-
differentiated state as some genes behaved as we would expect if they were initially 
XaXa and others if they were XaXi. On the other hand, the derivation of hEG lines was 
also a goal, as the PGCs while migrating to the gonadal ridges suffer a series of 
epigenetic changes, including X reactivation. The derivation and study of these lines 
would help us clear some aspects about the dynamics of XCI and reactivation. Several 
studies report the derivation of hEGs, but with low rates of efficiency associated with 
instability in culture and poorly chemical defined conditions in feeder-layers. Taking 
advantage of the definition of a ground state medium we derived one line maintained in 
feeder-free culture and defined conditions, which ended up being inconclusive 
respecting the XCI, as it was a male embryo. Though, we aim to continue the derivation 
of hEGs in future experiments. 
 
Keywords: X chromosome inactivation, dosage compensations, extra-embryonic tissues, 
embryonic germ cells  
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Resumo 
 
Existem diversas formas de determinação sexual no Reino Animal, variando desde 
determinação por factores ambientais, como por exemplo a temperatura de incubação 
dos ovos em crocodilos e outros répteis, passando por mecanismos baseados na 
constituição cromossómica que define os sexos no momento da fertilização, como nas 
aves e mamíferos onde os sexos são determinados por um par de cromossomas sexuais. 
Nas aves, as fêmeas são o denominado sexo heterogamético, pois definem-se por terem 
dois cromossomas sexuais diferentes (ZW), e os machos o sexo homogamético (ZZ). Em 
mamíferos a situação é a inversa, as fêmeas são o sexo homogamético (XX) e os machos 
o heterogamético (XY). O aparecimento destes métodos de determinação sexual trouxe 
vantagens evolutivas na medida em que em nada o clima poderia influenciar a razão 
entre machos e fêmeas na espécie. Contudo originou um problema de compensação de 
dosagem, já que, por um lado, as fêmeas possuem duas cópias de genes ligados ao X em 
comparação com apenas uma cópia nos machos e, por outro lado, genes localizados nos 
autossomas são maioritariamente expressos em dose dupla quando comparados com a 
cópia única dos genes localizados nos cromossomas sexuais, nos machos. A inactivação 
do cromossoma X surgiu portanto como um meio para resolver esta questão.  
A inactivação do X é imprintada em marsupiais, sendo o cromossoma paterno (Xp) 
preferencialmente silenciado. Em ratinho, a inactivação do X é estabelecida na fase de 
duas células, sendo também imprintada. Mais tarde, na massa celular interna, ocorre 
reactivação (E3.5) do Xp seguida de uma nova vaga de inactivação (E4.5), desta vez 
aleatória. Nas células do trophoblasto a inactivação mantém-se imprintada. A 
reactivação/inactivação do X nas células da massa celular interna é recapitulada in vitro 
pelas células estaminais embrionárias derivadas desta fase de desenvolvimento. Pouco 
se sabe sobre este processo em humanos e a inactivação imprintada do X tem sido alvo 
de intenso debate dentro da comunidade científica, com vários estudos a obter a 
conclusões contraditórias, devido à mistura de tecidos que constituem a placenta 
(trophoectoderme e mesoderme). Com este trabalho, tivemos acesso a material 
proveniente de clínicas de aborto, tanto aos tecidos embrionários em si, como aos 
variados tecidos extra-embrionários. O material recolhido era predominantemente do 
primeiro trimestre de desenvolvimento. O estudo realizado deu-nos claras evidências de 
que a inactivação do X em humanos é aleatória, pois nas amostras de placenta e de 
outros tecidos extra-embrionários (como o córion, amnios e cordão umbilical) 
observámos expressão tanto do cromossoma X materno como paterno. 
A inactivação aleatória do cromossoma X é regulada por uma região localizada no 
braço grande do cromossoma (Xq13) denominada centro de inactivação do X. Esta 
região é constituída por uma série de elementos genéticos que produzem longos RNAs 
não codificantes (ncRNAs) tais como Xist, Tsix, Xite, DxPas34 e Jpx/Enox. De entre estes 
destacam-se o Xist e Tsix pela sua importância em todo o processo. Em ratinho, sabe-se 
que o Xist começa a ser transcrito no futuro X inactivo (Xi) e que se espalha em cis a 
partir do seu ponto de transcrição para cobrir todo o cromossoma progressivamente, 
tornando-o inacessível a factores de transcrição. Por outro lado, no X activo (Xa) a 
manutenção da expressão de Tsix impede a transcrição do Xist e consequentemente, 
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previne o silenciamento. O silenciamento genético é mantido e reforçado através do 
recrutamento de de novo metiltransferases e pela metilação especifica de histonas 
(H3K27; H3K9; H4K20) e do DNA, especificamente em ilhas CpGs ao longo do 
cromossoma.  
Como já foi referido, a inactivação do X é recapitulada durante a diferenciação de 
células estaminais embrionárias, em ratinho e nalgumas linhas celulares humanas. A 
possível ligação entre a inactivação do X e a expressão de genes ligados à pluripotência 
é de elevado interesse e pode ajudar-nos a compreender um pouco melhor a dinâmica 
da inactivação. Do mesmo modo, o estado da inactivação do X nas células poderá ser 
mais um meio para caracterizar e avaliar as linhas celulares de acordo com o seu nível 
de pluripotência e capacidade de diferenciação para futuras aplicações clínicas. Neste 
projecto pretendemos desenvolver um protocolo para o estudo da origem parental da 
expressão de uma série de genes ligados ao X. Inicialmente escolhemos uma série de 11 
genes distribuídos ao longo do cromossoma cujos SNPs (single nucleotide 
polimorphisms) tinham sido previamente descritos na literatura. Ao genotipar e analisar 
a expressão dos genes e dos alelos ao longo da diferenciação de hESC pretendemos 
clarificar a nossa visão sobre a dinâmica e cinética deste processo, desde o início da 
expressão do Xist até ao total silenciamento do cromossoma. Por sua vez, acreditamos 
que este método poderá ser usado para avaliar o estado da inactivação do X em linhas 
celulares estaminais, de modo a avaliar o seu potencial. Para tal, usámos duas linhas 
diferentes de células estaminais embrionárias humanas, h2241 e h2258, uma feminina e 
a outra masculina, respectivamente. Avaliou-se a expressão dos genes ligados ao X e de 
genes associados à pluripotência em material não-diferenciado (D0) e material 
diferenciado (D7) através de RT-PCR quantitativo. O acesso a material feminino e 
masculino foi de igual modo uma boa oportunidade para poder avaliar a questão da 
compensação de dosagem entre machos e fêmeas. Segundo os nossos dados, ao fim de 
7 dias as células analisadas ainda não estavam suficientemente diferenciadas, embora 
se registasse já um decréscimo na expressão dos genes ligados à pluripotência e de 
certos genes ligados ao X, tendo 4 dos genes analisados mostrado um comportamento 
semelhante ao que seria de esperar aquando da diferenciação de células XaXa para 
XaXi. 
As células primordiais germinativas (PGCs), que vão dar origem aos gâmetas, têm 
sido vistas com grande interesse para aplicações clínicas, em paralelo com as células 
estaminais embrionárias. Isto porque, ao longo da sua jornada desde o seu local de 
determinação até às gónadas, estas células sofrem uma série de remodelações 
epigenéticas, incluindo a reactivação do X e o “reset” dos imprintings. A derivação em 
cultura de linhas celulares a partir destas células (EGs) tem um grande interesse não só 
devido ao seu potencial clínico, já que os problemas associados a genes imprintados são 
ultrapassados, mas, também, como um meio de estudar a inactivação/reactivação do 
cromossoma X. Outro objectivo deste trabalho foi exactamente a derivação de linhas 
celulares a partir de PGCs, já que o acesso a material de aborto do primeiro trimestre 
também permite o isolamento das respectivas gónadas. Contudo, esta derivação tem-se 
mostrado difícil, já que outros grupos que se debruçaram sobre este tema registaram 
dificuldades em manter a estabilidade das culturas, sendo em geral os métodos de 
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derivação muito pouco eficientes. A definição de um meio (N2B27+LIF+2i) que permite 
manter as células de ratinho em cultura no seu estado mais naive e sem o recurso a 
feeders, denominado de ground state, poderá ajudar-nos a estabelecer culturas de EGs 
tanto de ratinho como humanas. Das 11 gónadas que foram colocadas inicialmente em 
cultura, em apenas um caso registámos o aparecimento de colónias. Em experiências 
posteriores, onde experimentámos diferentes condições iniciais de cultura, ora 
introduzindo ou retirando os inibidores em diferentes timings, observámos o 
crescimento de pequenas colónias. Contudo não foi possível prosseguir com a 
experiência dado que não tinhamos no momento nenhuma linha de feeders em cultura. 
 
Palavras-chave: inactivação do X, tecidos extra-embrionários, compensação de 
dosagem, células germinativas embrionárias 
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I.Introduction 
 
I.1 Human Early Embryonic Development 
The moment of fertilization occurs when a viable spermatozoa reaches the zona 
pellucida surrounding the oocyte and successfully penetrates it, at this moment the cell 
membranes of the two cells fuse. This fusion causes the oocyte to resume meiosis: it 
completes the second meiotic metaphase and proceeds to anaphase, producing the 
second polar body. This fertilized oocyte is called the zygote. The chromosomes of the 
oocyte and sperm are enclosed within female and male pronuclei, but soon the 
membranes disappear in preparation for the first cleavage [1]. 
During the first days of development, the zygote travels down the oviduct and 
undergoes cleavage. Cleavage is not accompanied by cell growth but subdivides the 
zygote in smaller cells known as the blastomere. Around day 4, the embryo is 
constituted by 32 cells, having the appearance of a small mulberry, and for that is called 
morula. The cells from this stage will give rise to the embryo proper and to the extra-
embryonic tissues. Cells that will follow different paths start to segregate at 8-cell stage, 
where the blastomeres begin to flatten, developing an inside-out polarity: cells in the 
outer surfaces become convex and in the inner surfaces concave. This reorganization is 
called compaction. Some cells start to segregate to the center of the morula and others 
to the outside due to the development of differential adhesion between different 
groups of blastomeres. The inner cell mass (ICM) or embryoblast is than constituted by 
the central blastomeres and the peripheric ones constitute the outer cell mass or 
trophoblast. The blastocyst cavity is formed when, around day 4 of development, the 
morula begins to absorb fluid: as the hydrostatic pressure of the fluid increases the 
cavity is formed [1,2,3]. The embryoblast cells than form a compact mass at one side of 
the cavity and the trophoblast is organized into a thin, single-layered epithelium. The 
embryo is now called a blastocyst. At 
day 5, the blastocyst hatches from 
the zona pellucida being that way 
free to interact with the 
endometrium, in the uterus. The 
implantation occurs and the mucous 
membrane of the body of the uterus 
undergoes important changes and is 
then known as the decida. Between 
day 6 and 9 the embryo becomes 
completely implanted and 
surrounded by decida. Before 
implantation, the cells of the ICM 
start to differentiate into two 
distinct layers and at day 8 we can 
distinguish two layers of columnar 
cells – epiblast or primary ectoderm 
and the hypoblast or primary endoderm [3]. 
Figure 1: Development of the pre-implantation 
Blastocyst in Humans. (Image from: Appendix A: Early 
Development . In Stem Cell Information [World Wide Web site]. 
Bethesda, MD: National Institutes of Health, U.S. Department of 
Health and Human Services, 2009 Available at 
http://stemcells.nih.gov/info/scireport/appendixa) 
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I.1.1 The Human Extra-Embryonic Tissues 
The amniotic cavity is formed during the second week, appearing at day 8. A layer of 
epiblast cells will give rise to the amniotic membrane, which will enclose the entire 
embryo at eighth week of development. The chorion and the yolk sac are originated 
from the migration of cells from the hypoblast. The chorionic cavity is produced in 
conjunction with the development of the extraembryonic mesoderm. The chorionic villi 
invade the uterine decida and at the same time absorb from it nutritive materials for the 
growth of the embryo, secreting waste material. At first the villi are small and non-
vascular, and consist of trophoblast only, but they increase in size and ramify, while the 
mesoderm, carrying blood vessels, grows into them, becoming vascularized [3].  
The placenta connects the fetus to the uterine wall, and is the organ by means of 
which the nutritive, respiratory, and excretory functions of the fetus are carried on. It is 
composed of fetal and maternal portions. The fetal portion is constituted of villi from 
the chorion and the maternal one of decidua placentalis. This tissue starts to develop 
around the second and third week after fertilization and grows continuously [4]. The 
development of the placenta can be divided into three stages: the first one, around 
week 2, when the chorionic villi consist only of the trophoblast cells; the second when 
the villi are filled with extraembryonic mesoderm forming finger-like extensions into 
maternal decidua, around week 3. Initially these finger-like projections cover the entire 
surface of chorionic sac and later become restricted to the placental surface. And finally, 
in the third stage, chorionic secondary villi develop placental blood vessels within the 
core of extraembryonic mesoderm [5]. 
The umbilical cord is initially extra-embryonic mesoderm forming the connecting 
stalk within which the placental blood vessels (arteries and veins) form. In humans the 
placental blood vessels are initially paired, later in development only a single placental 
vein remains with a pair of placental arteries. This structure also contains the allantoids, 
an extension from the hindgut cloaca then urogenital sinus [2,5]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic diagram showing the derivation of embryonic and extra-embryonic tissues in 
humans. (Adapted from Developmental Biology. 6th edition.Gilbert SF. Sunderland (MA): Sinauer Associates. 2000) 
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I.2 Sex determination and Dosage Compensation 
 There are several ways of sex determination in the Animal Kingdom, varying from 
environmental factors, for example the incubation temperature in reptiles and some 
fish [6], to mechanisms based in chromosomal 
constitution [7]. In the first case, there is no need for 
dosage compensation mechanism as males and 
females are identically constituted and there are no 
sex specific chromosomes. This system is susceptive 
to sudden environmental changes involving average 
temperatures which shift the balance between sexes. 
Mammals have a genetic determination of sex at the 
moment of fertilization by chromosome constitution. 
It has been proposed that the sex chromosomes 
evolved from a pair of autosomes in the ancestors of 
today’s birds and mammals [6] by mutations on one 
of the autosome pairs and/or by acquisition of a sex-
determining gene(s) [8]. Two major genetic systems 
can be distinguished depending on which sex has two 
identical sex chromosomes (the so-called 
homogametic sex). In birds and some reptiles the 
female is the heterogametic sex (ZW) and the males 
are the homogametic sex (ZZ), while in mammals the 
females are XX and the males XY. The existence of 
these two systems suggests that this method of sex 
determination as evolved, at least, in two 
independent times during vertebrate evolution [7]. 
Several mutations and sex-linked genes 
accumulated during evolution, specially the loss of 
genes by the W and Y chromosome, led to 
mechanisms of dosage compensation. Though many 
differences are encountered between the two sex 
chromosomes, there is still one region, the Pseudo 
Autosomic Region (PAR), that is shared between 
both and that enables crossing-over during meiosis 
[9]. The appearance of the sex chromosomes led to 
two different problems: first the genes present in 
the heterogametic sex (ZW, XY) have only one copy 
compared to the autosomes, and second these 
genes are present twice in the respective 
homogametic sex, leading to unbalance.  
 
I.2.1 Solving the dosage balance issue 
As the appearence of the heteromorphic sex 
chromosomes in several species generated dosage unbalance between sexes and 
Figure 3: Schematic overview of the 
development of chromosomal sex 
determination and the need for dosage 
compensation mechanism. Initially 
males and females are chromosomally 
undistinguishable being sex determined 
by environmental cues. The acquisition 
of the SRY is the first step for sex 
chromosome emergence. With time, 
accumulation, of male specific genes in 
the proto-Y leads to a suppression of 
meiotic recombination with the proto-X 
and progressive degradation of the Y. 
Many X-linked genes are now present in 
one copy in the males compared with 
the two copies of the X and on all of the 
other autosomic genes.  To counteract 
this issue, mammals developed a 
dosage compensation mechanism: 
genes on the Xa are upregulated in 
males and in females X inacivation 
occurs (Adapted from Payer and Lee, 2008). 
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between autosomes and sex chromosomes, some mechanisms of dosage compensation 
was necessary [10]. There have been, at least, three different mechanisms proposed for 
dosage compensation: in flies, the single male X-chromosome is hypertranscribed to 
achieve the expression levels of the autossomes [11], worms developed repression 
mechanisms for both X chromosomes in females and hermaphrodites [12], and in 
mammals one of the X chromosomes is silenced early in development, resulting in a 
female mosaicism [10]. Little is known about the dosage compensation in birds. 
 
I.3 X Chromosome Inactivation (XCI) 
As referred, in mammals, the dosage compensation phenomenon occurs through 
inactivation of a single X chromosome in each female cell: X chromosome inactivation 
(XCI). Basically, chromatin on thefuture inactive X chromosome (Xi, Xa for the active X 
chromosome) is converted into heterochromatin, which remains condensed during 
great part of the cell cycle and replicates later during cell division. The Xi chromosome 
can be observed in the nuclear envelope of the female cells at interphase as a chromatin 
dense structure, named the Barr Body [13] often located at a perinuclear or a 
perinucleolar position in the nucleus of the cell. The initial inactivation of an X 
chromosome per cell has important phenotypic consequences. One of the first analyses 
on XCI was held by Mary Lyon [10] who observed patterns in mice hair color: if a female 
is heterozygotic for a pigmentation gene in X chromosome, strips or spots of one 
parental color alternate with the other parental color. With this observation Lyon took 
some important conclusions: XCI occurs at early stages of development in each cell and 
that inactivation is random, being the process irreversible; as the phenomenon occurs 
early in development, a region originated from one unique cell can have the same Xi, in 
this way all mammal female tissues are a mosaic of the two different types of cells. 
Besides that, some important exceptions to this hypothesis are well known, reinforcing  
these general ideas: XCI is a fact for somatic cells, not for germ cells - in female germ 
cells the Xi is reactivated just before cells enter meiosis, therefore in young oocytes both 
chromosome are active and XCI is de novo established in each generation [14,15]. 
Random inactivation is not an absolute rule, one of the main exceptions occurs, for 
example, in mice where first inactivation of the X is observed in fetal portion of the 
placenta where paternal X chromosome is inactivated [16], in other words the paternal 
X chromosome is imprinted. On the other side, not all X-linked genes are inactive in the 
Xi: some genes in both arms of the chromosome escape inactivation [17]. Finally, there 
are some male mammals that have color patterns similar to those of the heterozygotic 
females described by Lyon. It has been proved that these males are XXY, and that they 
suffer, as in females, random XCI, confirming the previous hypothesis. 
Inactivation is established in placental mammals (marsupials and eutherians) during 
early embryonic development through acquisition by the X chromosome of many 
chromatin changes that results in its transcriptional silencing [16,18]. Although these 
two groups have diverged relatively recently in the geological time scale (130 million 
years ago), they have different strategies for the X inactivation regarding the process 
itself [19]. Two forms of XCI have been described: i) paternal X chromosome imprinting 
in marsupials, which is considered the primordial form for dosage compensation in 
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Therians, and in extra-embryonic tissues of mice, rats and also in bovines though less 
extensively characterized, and ii) random XCI, in embryo proper of Eutherian mammals 
[20].  
 
I.3.1 XCI kinetics in mouse embryo versus human embryo 
In mice, XCI is initiated around 4-cell stage of pre-implantation development, when a 
single pinpoint area of Xist RNA is present, which will expand gradually to a full cloud. 
Here, the inactivation is paternally imprinted, meaning that the paternal X is always 
inactivated [21]. At day 3.5 (E3.5) reactivation of the imprinted Xi occurs in the Inner Cell 
Mass (ICM) while the imprinted inactivation is maintained in the trophoectoderm (TE) 
and in the primitive endoderm (PrE)[16]. Finally, random XCI initiates in the ICM around 
days 4.0 and 4.5, being recapitulated in in vitro ES cells differentiation assays [22]. 
The first signal of Xi repression is seen at 4 cell stage - exclusion of RNA polymerase II 
and absence of transcription of Cot-1 
repetitive elements [16,23] and from 
the 8 cells stage forward epigenetic 
marks appear - hypoacetylation of 
H3K9 and H3K4 hypomethylation 
[16]. In morula and blastocyst 
embryos, Eed/Ezh2 starts to 
associate with the Xi and we can see 
the incorporation of the histone 
variant macro H2A and the 
accumulation of H3K27 
trimethylation [24].  
Little is known about XCI dynamics 
in human embryos due not only to 
ethical issues concerning the usage 
of surplus embryos from IVF (in vitro 
fertilization) treatments and other 
human biological material (as, for 
example, material from abortions) 
and to difficulties in getting 
permissions and/or recruiting 
patients, but also to difficulties in 
obtaining good quality material, 
specially from the first cleavages of 
the embryo development. Despite 
that, some few studies have been 
performed in order to examine 
dosage compensation in humans 
[16,25,26,27]. It is known that the pinpoint of Xist cloud is still observed in human 
embryos at 8 cell stage [16,23,28] whereas in mouse, at this stage, a complete cloud is 
already formed (this can be due to the slower division rate of human embryos 
Figure 4: X reactivation and inactivation cycle in mouse. 
Chromosome colored white are active, partially inactive 
at pink and completely inactive at red. Epi: epiblast; ExE: 
extraembryonic ectoderm; m: maternal pronucleus; p: 
paternal pronucleus; PE: primitive endoderm; PGCs: 
primordial germ cells; PB: polar body; TE: 
trophectoderm; Xa:active X; Xm: maternal X; Xp: 
paternal X. (Adapted from Payer and Lee, 2008) 
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comparing to mouse). Human XCI may follow the same steps as mouse XCI, although the 
timings clearly differ, but no conclusive studies have, by this date, been performed in 
order to ascertain this issue.   
Another subject of debate is whether imprinted XCI occurs in humans similarly to 
what occurs in mouse. Though many studies have been performed [29,30] most of them 
are contradictory and no consensus has yet been achieved. Recently, Moreira de Mello 
and colleagues [20] stated that in human placenta random XCI occurs and that the 
contraditory results from previous studies were due to a poor set of SNPs analyzed and 
mostly due to a low number of placenta cells characterized in each study, since, they 
argue, the placenta is composed of patches of cells with the same X inactivated, and this 
fact could skew the results if not taken into due consideration. 
 
I.3.2 Molecular aspects of the XCI 
Random XCI is achieved in three genetic separable events: (1) to ensure that one X 
chromosome is inactivated per female diploid nucleus, the X-chromosome-to-autosome 
ratio is counted; (2) then, one X chromosome is “chosen” to be the future Xi, in a 
mutually exclusive way; (3) at last, silencing is initiated by coating of the chosen 
chromosome by ncRNAs, recruitment of silencing factors and chromatin condensation 
[31]. A region of the X-chromosome named Xic (X-inactivation center) located at the 
Xq13, it’s the main responsible for the regulation of these different steps. The Xic is 
composed by several genetic elements that produce long ncRNAs such as the Xist, Tsix, 
Xite, DxPas34 and Jpx/Enox [32]. Among these, Xist and Tsix stand out for their 
importance in the XCI process. Their coding sequences overlap in opposite strands of 
the X chromosome, being Xist negatively regulated by Tsix, in a fascinating example of 
antisense regulation. Xist encodes for a long ncRNAs with 17Kb, uniquely expressed 
from the Xi, since it coats the entire chromosome blocking the access to the 
transcriptional machinery [33,34]. Therefore Xist is essential for the phenomenon of 
silencing to occur in cis, being this evidenced by the observation that a chromosome 
deleted for Xist cannot be silenced [35]. On the other hand, in the Xa, Tsix expression is 
maintained, preventing upregulation of Xist and therefore preventing silencing. In its 
turn, Tsix is regulated by Xite, which is located ~10Kb upstream of Tsix and contains a 
Tsix specific enhancer [35].  
Another “hot theme” among the scientific community interested in understanding 
XCI is how the counting and choice process occurs and which molecules are involved in 
it. Several models have been proposed for this (for a review consult reference [36]) and 
also some few molecules have been indicated as activators or inhibitors such as Oct4 
and Rnf12 [37,38].  
After the first step of choice, in the mouse model, its known that in the Xi, the Xist 
transcripts spread in cis from their site of synthesis to coat the entire X-chromosome 
and that the DNA methylation starts in the Xic and than spreads to the rest of the 
chromosome [27]. On the Xa, in turn, the persistence of the Tsix expression prevents 
upregulation of Xist and therefore the silencing [39]. Some papers [40] suggest that this 
negative regulation operates through methylation as two regions flanking the Xist 
transcription start site show high levels of DNA methylation. In parallel, Tsix has also 
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been implicated in the regulation of DNA methylation with a direct association with the 
de novo methyltransferase Dnmt3a. The methylation of CpG islands in the DNA and 
histone specific methylations (H3K27; H3K9; H4K20) helps to maintain the silencing and 
are specific markers of the Xi. There has been some speculation about which kind of 
molecules does Xist recruits in order to achieve silencing, and the role of some 
molecules has been intensively studied: one example is the role of BRCA1, that has 
important functions in DNA damage pathways and meiotic sex chromosome inactivation 
[41]. Curiously, a Barr Body is not displayed in many breast cancers associated with 
deficiencies in BRCA1, suggesting that the Xi as either been lost or reactivated [42]. 
Other groups have focused in the polycomb group proteins as XCI regulators and several 
teams have characterized genetically PRC1 and PRC2 components [43]. It’s known that 
the highly conserved A-repeat region of Xist is crucial for its silencing function and that 
the other parts of the RNA ensure the cis-coating [44]. 
 
I.4 XCI and Pluripotency in Stem Cells 
Embryonic stem (ES) cells are derived from the inner cell mass of a blastocyst. They 
are defined by the ability of self-renewal being pluripotent cells, meaning that they have 
the capacity to form all cell types of the embryo proper and adult organism upon 
differentiation [45]. ES cells have a huge importance in medicine due to all their possible 
applications, but beside that, they constitute an ideal system to study early mammalian 
development from the pre-implantation period onwards [46] and to investigate XCI 
because, as previously mentioned, female mouse ES cells retain two Xa, initiating 
random XCI upon differentiation [22].  
Induced pluripotent stem (iPS) cells are typically adult somatic cells that are 
reprogrammed by a series of factors (Oct4, Klf4, Sox2 and c-Myc) into a pluripotent 
state [47] regaining properties of ES cells. These cells are a great study model that could 
help us understanding reactivation of the Xi and which factors are involved in this 
process. 
Though it’s clear that mouse ES cells are XaXa, in human ES (hES) cells different 
studies have achieved conflicting results [48,49]. Unlike mouse ES cells, most of the 
female hES cell lines exhibit a Xi already in the undifferentiated state, but other 
undifferentiated lines have both X active and also recapitulate XCI upon differentiation. 
Curiously, some cell lines behave differently in distinct laboratories with some sub-
clones showing random XCI whereas others show XCI hallmarks prior to differentiation 
[50].  
Silva et al [49] have performed a study using 11 characterized hES cell lines and 
identified 3 classes of cells lines based in their XCI profile: Class I only displays XCI upon 
differentiation; Class II and III have a Xi in the undifferentiated state, but in the third one 
Xist expression is lost though other markers for inactivation are still present, such as 
Cot-1 RNA exclusion from the chromosome. Also a highly skewed XCI pattern was 
observed in female lines, but the paternal origin of the Xi couldn’t be determined [51].  
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Recent findings also indicate that XCI is suppressed in female ES cells through the 
action of Nanog, Sox2 and Oct4, which are important markers of pluripotency [52]. It 
has been seen that activation of XCI requires down-regulation of these factors and up-
regulation of some X-encoded activators, such as Rnf12, previously mentioned and also 
involved in differentiation processes [37]. These facts suggest that XCI is regulated by 
the same factors involved in pluripotency and differentiation. In this way the study of 
XCI in ES cells could provide us information about the pluripotent state of the cell lines, 
contributing to their characterization and, on the other hand, ES cells can help us 
understand XCI dynamics. In the same aspect, studies involving iPS lines can provide 
helpful information about the inactivation/reactivation process and kinetics and at the 
same time, the state of the X-chromosomes can be indicative of the pluripotency degree 
among different lines.  
 
 
 
 
Figure 5: Schematic representation of the events occurring during stem cell differentiation. At the 
undifferentiated stage we can see two pinpoints of Xist expression (blue points) in the cells (at grey). 
During differentiation Xist expression is upregulated in one of the chromosomes until it covers it 
completely, in differentiated cells. Epigenetic markers of X repression start to appear, like histone 
methylation and later CpG methylation. (Adapted from The Cell Biology of Stem Cells, Volume 695 from Advances in 
experimental medicine and biology, Eran Meshorer, Kathrin Plath, Springer Science, 2010) 
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I.4.1 XCI and Germ Cells 
Mouse primordial germ cells (PGCs) are derived from a small subset of epiblast cells - 
the progenitor population which is defined around day 6.5 of development - at the base 
of the mesodermal allantoids around day 7.25. After their specification they initiate a 
long journey - migrating through the forming hindgut and the dorsal mesenterium till 
the genital ridges [53] where they arrive between 10.5 and 12.5 days postconception 
(dpc). These cells suffer along their migration a series of epigenetic changes and 
remodelations such as: change of histone modifications and histone variants, DNA 
demethylation, removal of parental imprintings and X-chromosome reactivation [54]. 
This means that in PGCs the parental genomes become epigenetically equivalent for a 
period of time. The sex imprints in the germ cells are re-established later in 
development, in males, and after birth, in females [53,55]. In humans, PGCs appear in 
the gonadal ridge during the fifth and sixth week of development [53] but, again little 
more is known about the reactivation and reprogramming processes, for example, when 
does the specification process occurs? 
  
I.4.1.1 Derivation of human Embryonic Germ cells (hEGs) 
Human embryonic germ cells (hEGS) have been pointed as an alternative pluripotent 
stem cell resource, based on similarities with hES cells, since before differentiation they 
share the expression of basically all pluripotent markers, including NANOG and Oct4 
[53], and share the capacity of germ line transmission in chimaeric mice [56] The 
interest in the development of cell lines from PGCs is due to the fact that these cells 
undergo X chromosome reactivation and epigenetic reprogramming, including the 
erasure of imprints. This could overcome the issues with the imprintings and XCI in hES 
cells. Several laboratories have attempted successfully the derivation of mouse EG cells 
from pre-migratory, migratory and post-migratory PGCs cultured in the presence of LIF, 
KITI and bFGF on mouse embryonic fibroblast cells (feeders) [57]. On the other hand, in 
humans the same has been attempted using 5-9 weeks after conception gonads (that 
corresponds to 7-11 weeks of gestational age), on similar conditions as in mice [58] but 
not very successfully. Although the hEG showed pluripotency markers also seen in hESC 
such as Alkaline Phosphatase, SSEA1, SSEA3, SSEA4, TRA1-60, TRA1-81, Oct4, NANOG 
and hTER [58,59], but they differentiate quite easily, cannot be maintained in culture for 
long periods, neither freeze-thawed and nor give rise to teratomas in mice.  
With some recent reports [60] defining a ground state medium for mouse cells feeder-
free culture, achieved by adding to culture some inhibitors (PD0325901 and CHIR99021) 
plus LIF (leukemia inhibitor factor), the so-called 2i medium, it would be of extreme 
interest the derivation of mEGs and hEGs in these conditions. The culture conditions 
associated with the ground state have been optimized to avoid the use of less-specified 
batch-dependent products like fetal calf serum and avoid the use of a feeder cell layer 
[60].  
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Age* 
(weeks) 
feeders Medium Additivesa efficiency duration 
Shamblott et 
al [61] 
5-9  DMEM + 15% FBS 
hrLIF, forskolin,  
hrFGF 
(1-2ng/mL) 
variable 20-25 passages 
Turnpenny 
et al [58] 
7-9  
KO-DMEM + 15% 
KO-SR/ES-FBS 
hrLIF, forsfokolin, 
hrFGF (4ng/mL) 
14% 10-12 passages 
Park et al 
[62] 
9  DMEM 15% FBS 
hrLIF, forskolin,  
hrFGF 
(1ng/mL) 
Unstated; 1 
line 
1 year 
Liu et al [63] 6-8  DMEM 15% FBS 
hrLIF, forskolin,  
hrFGF 
(1ng/mL) 
Unstated; 
multiple 
specimens 
pooled 
6 months 
Pan et al 
[64] 
6-9  
KO-DMEM + 15% 
FBS/ KO-SR 
hrLIF, forskolin,  
hrFGF 
(1ng/mL) 
5% 15 passages 
Table1: Summary of the methodology used in different reports for hEGs derivation 
a
all added hrLIF at 1,000 U/ml and forskolin at 10 µM. 
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; hrFGF2, human recombinant fibroblast growthfactor 2; 
hrLIF, human recombinant leukemia inhibitory factor; KO, knockout; SR, serumreplacement 
*post-conception age, gestational age is considered when when menstruation is lost, two weeks after age of conception. 
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II.Objectives 
 
The main goal of this work was to elucidate the dynamics of X-chromosome 
inactivation in humans. 
For that we aimed to properly characterize X-chromosome inactivation activity and 
kinetics in human tissues, both the embryonic and extra-embryonic tissues. Thus we 
developed an assay based on SNP analysis and parental specific transcription to 
determine the status of X inactivation. To better understanding if the imprinted form of 
XCI occurs in humans similarly to mice, since there are many contradictory results about 
this particular issue, both in vivo and in vitro.  
At the same time, we aimed to comprehend the dynamics of XCI in the differentiation of 
human embryonic stem cells and the possible connection with pluripotency factors 
expression. The access to both male and female cell lineages is likely to gives some 
insights about the dosage compensation phenomenon before and after differentiation. 
With this, we also intended to verify if it’s possible to use the XCI status to characterize a 
lineage pluripotency.  
Finally, we aimed to derivate human embryonic germ cell lineages (hEGs) from 
different periods of development, not only because they represent a future outbreak in 
the history of stem cell research but also in order to study the XCI along the gonads 
development and to understand when does reactivation occur.  
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III. Material and Methods 
[all procedures were approved by the LUMC and Ghent University Hospital Ethical 
Committee] 
 
III.1 BIOLOGICAL MATERIAL 
In order to understand X chromosome dynamics in humans we studied different 
types of human material. 
To understand the dynamics of the inactivation along development we had access to 
complete abortion material from the first trimester of gestation, both embryonic and 
extra-embryonic tissues such as: placenta, chorion, amnion and umbilical cord. We also 
collected decida tissue, which enables us accessing to the maternal DNA. The material 
was taken fresh from an abortion clinic CASA (http://www.casa.nl/en), located in Leiden 
and den Haag (the Netherlands). In the moment of collection, and when possible, the 
embryo gonads were also collected. The placenta samples were collected from different 
parts of the tissue.  
To have insight of the events and timings behind the X inactivation/reactivation we 
used human stem cell lines (h2241 and h2258) that were derived and differentiated by 
the Department for Reproductive Medicine of Ghent University Hospital (Ghent, 
Belgium) 
 
 
III.2 DETERMINATION OF EMBRYOS SEX 
 
III.2.1 Genotyping 
In order to verify the embryo sex, we extracted DNA from embryo tissue samples by 
digestion with Proteanase K (Promega) in the lysis buffer described at appendix IV (1µl 
proteanase K:50ul lysis buffer) at 55°C and 750 rpm, until the tissue fragment was 
completely digested (1 to 4 hours, depending on the size of the sample). The final step 
was the enzyme inactivation at 95°C for 10 minutes. After digestion, 1µL of the solution 
was directly used for PCR whose conditions are summarized at table 2. Primers were 
designed to amplify AMELY and AMELX, present in X (p22.31) and Y (p11.2) respectively 
(5’-CTGATGGTTGGCTCCAAGCCTGTG-3’, 3’-TAAAGAGATTCATTAACTTGACTG-5’). Both 
genes share 84% sequence identity [65]. At the end, the fragments were visualized by 
agarose gel electrophoresis. The majorities of the PCRs were performed using REDTaq® 
ReadyMix PCR with MgCl2 (Sigma-Aldrich), although when some samples didn’t amplify 
correctly we used SilverStar DNA polymerase (Eurogentec) (0.4µL of enzyme, 2.5 µL 10x 
reaction buffer, 2.5 µL of dNTPs 2.5mM each, 0.5 µL of each primer, 1 µL MgCl2 and 
16.6 µL of H2O) using the same PCR program as for RedTaq. 
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III.2.2 Agarose gel electrophoresis 
This technique was used to verify the PCR reactions for sequencing, to separate and 
purify bands and to check the efficiency of the purification steps, and mostly for 
visualizing PCR reactions. Agarose (UltraPure™ Agarose from Invitrogen) was dissolved 
in 1x TAE into a concentration of 1.5% in most cases, although when necessary a better 
separation of bands or for visualizing smaller bands it was used a 2% final concentration 
instead. To visualize the bands, ethidium bromide was added to a final concentration of 
0.2µg/mL and imaging was performed in AutoChemi System UVP (Bioimaging Systems). 
The samples were loaded directly into the gel, as we were using REDTaq® DNA PCR mix 
which already includes the loading buffer. Usually, a 1Kb DNA ladder was added to 
estimate the fragments size and the gels were runned at a 100V electric current until 
the necessary separation was achieved (30 to 45 minutes).  
 
III.3 DEVELOPMENT OF PARENTAL SPECIFIC TRANSCRIPTION ANALYSIS 
In order to understand the parental origin of the active X chromosome on the 
embryonic and extra-embryonic tissues, we have been developing an assay based on 
SNP analysis of X-linked gene transcripts covering the entire chromosome. The target 
genes and respective SNPs were chosen based on Moreira de Mello et al [20] table of X-
linked genes. 
For each SNP, we searched for a restriction enzyme recognition site that would be SNP 
sensitive using DNASTAR Lasergene® Core Suite sequence analysis software. At the 
same time, we also searched for recognition sites of methylation sensitive restriction 
enzymes.  
 
III.3.1 DNA Extraction and Purification 
To obtain DNA from the different tissues we digested each one by adding 80µL of 
Proteanase K Buffer, 260 µL of Rnase free H2O (Qiagen), 20µL of 10% SDS, and 10 µL of 
ProtK  at 10 mg\ µL (Promega) on a 1.5 mL eppendorf. The samples were digested 
overnight at 55°C and 750 rpm on termomixer. After digestion, we let the eppendorfs 
cool down a little bit before adding 120 µL of NaCl 5M ice cold. The tube was inverted a 
few times to mix and then centrifuged at 13000 rpm at 0°C for 5 minutes. 400 µL of the 
supernatant was transferred into a clean eppendorf and 1mL of 95% Ethanol ice cold 
was added. The samples were kept at -20°C for a minimum period of one hour and then 
 
qPCR program 
temperature time 
Reaction Mix 95°C 5 minutes 
10 µL of RedTaq PCR mix 95°C 1 minute 
10 µL of H2O 60°C 30 seconds 
0.5 µL of reverse primer (10mM) 72°C 2 minutes 
0.5 µL of forward primer (10mM) 72°C 10 minutes 
add 18µL of mix per sample 4°C ∞ 
Table2 : PCR conditions for AMEL XY 
35x 
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centrifuged at 13000 rpm at 0ºC for 5 minutes after which the supernatant was 
discarded. Finally, 1mL of 70% Ethanol ice cold was added, the samples were 
centrifuged again at 13000 rpm at 0°C for 5 minutes and the supernatant was discarded. 
This wash was repeated the necessary times until a clean pellet was obtained. We let 
the samples dry out the ethanol before ressuspending the pellet with 50 µL of Rnase 
free H2O. 
The DNA concentration was measured using the NanoVue Plus TM (GE Healthcare) and 
the samples were stored at -20°C ,when not immediately used.  
 
 
III.3.2Restriction enzyme assay 
 
III.3.2.1 SNP sensitive Restriction Enzymes 
First a PCR was performed on the target genes and the reaction was checked by 
agarose gel electrophoresis. The restriction reaction of BseRI and MfeI enzymes (New 
England BioLabs®) was performed accordingly with table 3. 
 
 
 
 
 
 
 
 
 
 
III.3.3 HUMARA - Human Androgen Receptor Assay 
This assay is commonly used for X inactivation studies as the human androgen 
receptor gene, mapped at Xq12, has a polymorphic short tandem repeat, CAGn, with 
87% of heterozygosis, meaning that if both X chromosomes have different HUMARA 
alleles with different sizes we can detect them by different length PCR products. The 
CAG repeats contain two methylation-sensitive HpaII enzyme restriction sites.  
DNA digestion was performed with HpaII (New England Biolabs), in a final volume of 
10 µL (fulfilled with H2O) we mixed 200ng/µL of DNA with 0.5 µL of HpaII and 1 µL of the 
respective Buffer 1. The incubation was performed overnight (at least 16 hours) at 37°C 
and the enzyme was inactivated during 20 minutes at 60°C. 
Next, a PCR was performed to amplify a region of the Humara gene, under the 
conditions described in table 4, with both undigested and digested DNA. Posteriorly we 
confirmed the results by agarose gel electrophoresis.  
 
 
 
 
 
Reaction Mix  
16,5 µL of H2O Incubation 
2 µL of Buffer J Temperature time 
1 µL of DNA (100 µL/ng) 25°C 4 hours 
0.4 µL of BseRI or 1 µL of MfeI 65°C 20 minutes 
Table 3: Conditions for the Restriction with BseRI and MfeI 
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III.3.3.1 Fragment run 
The digestion products were sent to analysis by Fragment Run at LGTC (Leiden 
Genome Technology Center) facilities (http://www.lgtc.nl/) in the LUMC. The samples 
were sent in a MicroAmp® Optical 96-Well Reaction Plate (Applied Biosystems). The 
plates were prepared with 3µL of the PCR products and respective digestion products, 
all in duplicate, for each sample. To each well 12µL of Formamide mix was added. The 
Formamide mix was prepared using 30µL of GeneScan™ 500 ROX™ (Applied 
Biosystems), which was our marker, and 1.2mL of Hi-Di™ Formamide (Applied 
Biosystems).  
The results were analyzed using GeneMarker® v1.90 from SoftGenetics. When two 
distinguishable peaks were observed, the sample was considered heterozygotic for the 
HUMARA.  The ratio between the individual peaks, corresponden to Xm and Xp, was 
calculated by dividing the individual peak area by the total area of the heterozigotic 
peaks, provided by the software. Assuming that the area occupied by both peaks 
represents 100%, we than calculated the percentage of allele expression, defined by the 
percentage that each individual peak represents in the total area [66].  
 
III.3.4 Single Nucleotide Polimorphisms (SNPs) Detection and Analysis 
X-linked genes and respective SNPS were chosen based on Moreira de Mello [20] 
table of X genes and. the selection was made in order to cover the entire chromosome. 
The primers are described at [67,68] and they were previously used for quantitative RT-
PCR The primers and SNP information is resumed in the appendix II. To genotype the 
different samples for the SNPs, first we used the genomic DNA previously extracted and 
we performed a PCR to amplify the genes of interest, whose conditions are described in 
table 5. The PCR products were then checked by agarose gel electrophoresis. The 
remaining PCR product was purified using QIAquick® PCR purification Kit Protocol from 
Qiagen, and following the manufacture instructions. Once again, the purification was 
checked by agarose gel electrophoresis and concentrations measured on NanoVue 
Plus™ (GE HealthCare). 
 
 
 
 
 
 
 
DNA PCR mix HPAII treated DNA mix 
PCR Program 
temperature time 
RedTaq Ready Mix 10 µL 10 µL 95°C 5 minutes 
Primer Forward 0.5 µL 0.5 µL 95°C 45 seconds 
Primer Reverse 0.5 µL 0.5 µL 60°C 30 seconds 
H2O 13 µL 9 µL 72°C 30 seconds 
Dosage of mix per well 24 µL 20 µL 72°C 10 seconds 
Template (100ng/ µL) 1 µL 5 µL 10°C ∞ 
Table 4: PCR conditions for the HUMARA assay. 
35x 
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III.3.4.1 Sequencing 
The samples were prepared in 8 tubes PCR strips (Qiagen), using 1.5µL of the purified 
DNA and 1.5µL of reverse or forward primer (10mM) and added water until a final 
volume of 15µL and finally, sent to sequence at the LGTC facilities (http://www.lgtc.nl/), 
localized at the LUMC. The results were analyzed using Applied Biosystems software 
Sequence Scanner, Bioedit (http://www.mbio.ncsu.edu/bioedit/bioedit.html) and BLAST  
(http://www.ncbi.nlm.nih.gov/BLAST/).  
 
III.3.5 In Silico Analysis 
In order to enlarge our pool of X linked genes in this study, beside the already 
described genes, we made use of the online database services currently available to 
search for extra X-linked genes (NCBI; Ensembl), to design new primers for the chosen 
genes (OligoPerfect™ Designer; UCSC Genome Browser) and to screen for SNPs localized 
at the amplificated regions (Human SNP Database; NCBI) with higher heterozigosity in 
the European population.  
 
III.4 ANALYSIS OF GENE EXPRESSION 
 
III.4.1RNA Isolation and reverse-transcriptase 
RNA isolation was performed using Qiagen RNeasy Micro Kit for a maximum of 45 μg 
of RNA or RNeasy MiniKit for a maximum of 100 μg RNA, and following the manufacture 
instructions and recommendations. Tissues were manually disrupted using a mortar, in 
dry ice with 500 µL of RTL in a 1.5mL eppendorf. After disruption and in order to discard 
the tissues debris, eppendorfs were centrifuged at 13000 rpm for 5 minutes and the 
supernatant was transferred into a clean eppendorf. From this step onwards the 
manufacturer protocol was followed. 
The cDNA was obtained using iScript™ cDNA Synthesis Kit from BioRad and following the 
manufacture instructions. As a negative control for DNA contamination, for all the 
samples an additional reaction was performed without the reverse transcriptase 
enzyme and both sample and control were tested by PCR amplification of housekeeping 
genes and/or by RT-PCR. 
 
 
 
 
qPCR program 
temperature Time 
Reaction Mix 95°C 3 minutes 
10 µL of RedTaq PCR mix 95°C 30 seconds 
10 µL of H2O 60°C 1 minute 
0.5 µL of reverse primer (10mM) 72°C 30 seconds 
0.5 µL of forward primer (10mM) 72°C 10 minutes 
add 18µL of mix per sample 4°C ∞ 
35x 
Table 5: PCR conditions for the PCR on the X-linked genes. 
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III.4.2Quantitative RT-PCR 
To infer the expression levels of several genes of interest for this project, we used 
quantitative reverse transcriptase PCR. The experiments were prepared in a 96-well 
plate (BioRad), on ice, and all samples were analyzed in triplicate, with the respective 
negative control (as described in the previous section). For each plate two house-
keeping genes were used, HARP (5’-CACCATTGAAATCCTGAGTGATGT-3’, 3’-
TGACCAGCCCAAAGGAGAAG-5’) and GAPDH (5´-TGCACCACCAACTGCTTAGC-3’, 3’-
GGCATGGACTGTGGTCATGAG-5’) as a control. To minimize possible pippeting errors, the 
reaction mix (at table 6) was prepared in two times: SYBR green + template and H2O + 
primers and the two mixes were pippeted using special long tips (Greiner Bio-One filter 
tips). The plates were covered with adhesive PCR film (Eppendorf) and briefly 
centrifuged to get rid of bubbles that could disturb the reading of the fluorofores.  
Results were visualized using CFX Manager™ Software (BioRad). Possible contaminations 
and primer dimmers were verified through the melting curve where, for a good result, 
we expect to see only one peak. The respective Cts (cycle treshould, which is defined as 
the number of cycles required for the fluorescent signal to exceed the background) were 
used to evaluate the expression levels as they are inversely proportional to the amount 
of target in the sample. Normalization of the data was performed using the geometric 
mean of the two house-keeping genes, per plate.  
The pluripotency primers [20,69] were tested for qPCR by performing a series of 
increasing dilutions using as a template Stratagene® qPCR Human Reference Total RNA, 
the results were used to build an efficiency curve for each primer set (option available 
with the software). Primers information is resumed in appendix II. 
 
 
 
qPCR program 
temperature time 
Reaction Mix 95°C 3 minutes 
10 µL of SYBR Green® PCR Master Mix 95°C 15 seconds 
9 µL of H2O 60°C 1 minute 
0.5 µL of reverse primer (10mM) 72°C 30 seconds 
0.5 µL of forward primer (10mM) 72°C 10 minutes 
1µL of template 
Melt curve: 65°C to 
95°C 
0,5°C each 5 
seconds 
 
 
III.5 CELL CULTURE 
 
III.5.1 hEGs Derivation 
Gonads from 8 to 11 weeks of development were collected fresh and preserved in 
DMEM 7.5% plus 25mM of HEPES. The gonads were washed with PBS (Gibco) three 
times, in order to get rid of any traces of medium and then incubated with 0.05% 
trypsine (Invitrogen) for 15 minutes, at 37°C. The material was ressuspended, and if not 
in single cell, incubated for an extra 10 minutes. To inactivate the trypsine, 100 µL of 
N2B27 medium was added. 
Table 6: PCR conditions for the qPCR. 
40x 
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The primary culture was established in 6-well plates, previously coated with 0.1% 
gelatin (1hour at 37°C in the incubator or overnight at room temperature) with 
N2B27+2i+LIF or EG+ FGF+ LIF (all mediums and solutions are described at appendix III). 
Culture was performed in an incubator with controlled conditions at 37°C with 5% CO2 
and 20% O2.  
On the second day FGF was withdrawn from culture and at day 7 the mediums were 
refreshed. At day 8 we screened for any colonies growth and we split the colonies.  
 
III.5.1.1 Splitting the Cells 
hEGs were routinely split 3 days per week. First the cells were washed 3 times with 
PBS and then trypsinized (0.05% trypsine) for 3 min after which 1 mL of medium was 
added. Cells were centrifuged for 3 minutes at 1100 rpm, ressuspended in the 
correspondent medium and passed in 1/5 or 1/10 density to plates pre-coated with 
0.1% gelatin.  
 
III.5.1.2 Cryopreservation 
To cryopreserve the cells, first they were 3 times washed with PBS and trypsinized for 
3 minutes. Trypsine was inactivated by adding 1 mL of the correspondent medium. Cells 
were ressuspended in 500µL of regular medium and added 500 µL of cryopreservation 
medium. Cells were preserved at -80°C if to use in the next month or in liquid nitrogen 
for long term STORAGE. 
 
III.5.1.3 Thawing of the cells 
Cells were thawed in a bath at 37°C for 6 minutes, centrifuged for 3 minutes at 1100 
rpm, ressuspended in the correspondent medium and placed in culture. 
 
III.6 IMMUNOSTAINING 
Cells were grown on glass coverslips and/or in 12-well plates without the gelatin 
coating at the exact same conditions as in the main culture. After 48 hours the medium 
was removed, cells were washed once with PBS and fixed overnight at 4°C with 4% 
paraformaldehyde. After that, cells were washed once with 1x PBS and permeabilized 
with 0.1% TritonX/PBS for 8 minutes at room temperature. Blocking was performed with 
1% BSA in 0.05% Tween/PBS for one hour at RT. The first antibodies were diluted in 
blocking solution and incubated overnight at 4°C. After, cells were washed for 5 minutes 
at RT with 0.05% Tween/PBS. The second antibodies were again diluted in blocking and 
incubation was performed for one hour at RT. Finally cells were washed once with 
0.05% Tween/PBS, 5 min at RT and mounted with VECTASHIELD® HardSet™ with DAPI. 
The primary antibodies used were SSEA1 (480) (Santa Cruz SC21702); SSEA3 (Millipore 
MAB4303): SSEA4 (Santa Cruz SC59368); OCT3/4 (Santa Cruz SC8628); SOX2 (Millipore 
AB5603); TRA 1-60 (Millicon MAB4360); TRA 1-81 (Millicon MAB4381) and NANOG (R&D 
Systems AF1997). SSEA1, SSEA3, SSEA4, TRA 1-60 and TRA 1-81 were used in 1:50 
concentrations; SOX2, NANOG and OCT3/4 in 1:200. All secondary antibodies were used 
in 1:200. For secondary, goat anti-mouse IgM; goat anti-rat IgM; goat anti-mouse IgG; 
donkey anti-goat; donkey anti-rat and donkey anti-mouse were used.  
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Slides were visualized using an Olympus AX20 microscope. 
Images were treated using ImageJ and Adobe Photoshop CS2 (version 9.0) were color 
and contrast were optimized in a way that affected equally the entire image.  
 
III.7 ALKALINE PHOSPHATASE STAINING 
Cells were grown on glass coverslips and/or in 12-well plates without the gelatin 
coating at the exact same conditions as in the main culture. After 48 hours the medium 
was removed, cells were washed once with PBS and fixed overnight at 4°C with 4% 
paraformaldehyde. Cells were washed 3 times with PBS0 (no Ca+ and Mg-), for 5 minutes 
at RT. After, cells were washed for 60 minutes with 70% Ethanol at 4°C after which they 
were washed twice with tap water. The staining solution was always prepared fresh and 
is composed of 1% veronal, 0.12% MgCl2, 0.02 mg/mL of αnaphthyl phosphate and 
1.0mg/mL of Fast Red TR – 0.5 mL of each reagent was added to 3mL of H2O. The 
staining solution was added for 8-20 minutes, until the staining starts to appear. The 
reaction is stopped by washing with H2O and the slides mounted with 70% glycerol.  
 
III. 8 FLUORESCENT ACTIVATED CELL SORTING - FACS 
Cells were trypsinized until single cell, washed 3 times with PBS and ressuspended in 
1 mL. Cells were distributed to clean eppendorfs and primary antibodies, SSEA1, SSEA3 
and SSEA4 were added in a 1:50 concentration. Incubation was performed on ice for 20 
minutes, shaking every 5 minutes. Cells were centrifuged at 1100 rpm to wash the 
primary antibody and ressuspended in PBS. The secondary antibody was added for 30 
minutes, on ice, shaking every 5 minutes. Cells were centrifuged and ressuspende on 1% 
FCS/PBS solution.  
The FACS sorting was performed at the Flow Citometry Unit in the LUMC facilities into a 
96-well culture plate. Cells were placed in culture with N2B27+2i+LIF medium, and 
colonies growth was checked after a week. 
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IV-Results  
 
IV.1 XCI dynamics in human early development 
 
As referred, many contradictory results have been presented concerning the 
imprinted form of X inactivation in humans. With this work we had the opportunity of 
having access to human abortion material, including the extra-embryonic tissues. The 
material was collected gradually during the months of this project. Appendix I resume all 
the samples that we collected and the several tissues of each sample (umbilical cord, 
chorion, amnion, placenta and proper embryo). For each embryo we were able to 
isolate the maternal decidua. Samples were predominantly from the first trimester of 
gestation, with ages varying from 4 to 12 weeks. Tissue samples from the embryo were 
used to determine the sex by regular PCR with a pair of primers that amplifies the 
amelogenin genes - AMELX and AMELY - each located at the X and Y chromosome 
respectively, and with variable lengths. In this way, if the sample is female one band will 
be visualized in the gel, correspondent to AMELX, and in case of a male two bands will 
show up, one for AMELX and the other for AMELY (figure 6). 
As one of our goals was to determine if indeed imprinted XCI occurs in the 
trophoectoderm (TE) in humans, we decided to develop an assay to 
distinguish which X chromosome is active in the different tissues. We 
based our analysis on a set of genes distributed along the X 
described previously in Moreira de Mello work [20]. Making use of 
the available online databases we have searched for SNPs localized 
on the desired genes. The next step was to be able to distinguish 
between the different alleles of each gene, for that we searched for 
available restriction enzymes with recognition sites localized at the 
SNP for each gene. Of the eleven genes that constituted our 
analysis, only two had a restriction recognition site localized within 
the SNP: XIST and ATRX. For XIST, we identified the MfeI enzyme 
and for ATRX the BseRI. The enzymes cut the sequence in the 
presence of one of the alleles (MfeI cuts in the presence of an A in 
XIST and BseRI cuts in the presence of a C in ATRX). This makes 
possible to distinguish which alleles are present in the embryo and 
mother samples. The paternal X chromosome is identified by 
exclusion. In order to identify the parental chromosomes we need to have 
heterozigosity, because if the mother and embryo are homozygotic for the alleles it is 
impossible to distinguish which chromosome is which. The best situation is to have the 
embryo heterozygotic and the mother homozygotic for the alleles in study. As SNPs by 
definition have a low rate of incidence in a population, ideally we would like to have a 
larger set of genes with SNPs that have a restriction enzyme recognition site.  
 
 
 
Figure 6: AMEL XY 
PCR runned at 
100mV for 30 
minutes in a 1.5% 
agarosis gel. One 
band means that we 
are in presence of a 
female, two bands 
of a male.  
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The first step was to genotype each mother and embryo, to confirm if we could 
distinguish the parental chromosomes before progress with the rest of the analysis in 
the cDNA of the extra-embryonic tissues. This initial analysis was performed in a set of 
14 samples. Yet, none of the pairs of mother/embryo samples ended up being 
informative (Figure 7A) for the SNP localized at the restriction enzyme recognition site 
(Figure 7B). Because of that we decided to use one sample with a complete set of extra-
embryonic tissues collected (C1 for ATRX) where the embryo was heterozygotic to check 
if both alleles were being expressed or not. In the case of imprinted XCI we would 
expect to see only one of the alleles (or C or G), however, the results (Figure 7D) show 
both alleles being expressed, except for placenta 4, which could be evidential for 
random inactivation or could mean that the gene escapes inactivation. The different 
intensities of each allele band could be indicative of differential expression or 
incomplete restriction.  
    ATRX 
(BseRI)  
XIST 
(MfeI)  
    
ATRX 
(BseRI)  
XIST  
(MfeI)  
B1  
Mother  CC  AG  
F3  
Mother  CG  AG  
Embryo  CC  AG  Embryo  CC  AG  
B2  
Mother  CG  AA  
H1 
Mother  CC AA 
Embryo  GG  AA  Embryo CC AA 
B3  
Mother  CG  AA  
I3 
Mother  CC AA 
Embryo  CG  AA  Embryo CC AA 
B4  
Mother  CC  AA  
L1 
Mother  CC AA 
Embryo  CC  AA  Embryo CC AA 
C1  
Mother  CG  AA  
L2 
Mother  CC GG 
Embryo  CG  AA  Embryo CC GG 
F1  
Mother  CG  AA  
M1 
Mother  CC AA 
Embryo  CC  AA  Embryo CC AA 
F2  
Mother  CG  AG  
N1 
Mother  CG AG 
Embryo  CC  AA  Embryo CG AG 
A  
Figure 7: A) Table with the genotyping for ATRX and XIST for the different samples analyzed, at bold are the 
heterozygotic samples. B) Recognition sequence of MfeI and BseRI, the arrow represents the site of the cut. C) 
Example of a restriction assay with MfeI, 1.5% agarose gel, runned at 100V for 30 minutes. D) Restriction with 
BseRI in the complete set of the sample C1. For each sample, DNA (first well) and cDNA (second well) is 
represented. 1.5% agarose gel, runned at 100V for 30 minutes. 
D  
B  
C  
   
AA AA AG AG AG AG 
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When analyzing all the results for each gene and calculating the frequency of the 
alleles in the samples, we realize that although the heterozigosity is relatively high in 
ATRX (55.4% of CG, 64% of CC and 0.6% of GG), the same doesn’t happen in XIST (31% 
of AG, 67.8% of AA and 0.2% of GG).  
Several studies on X inactivation have been performed using the HUMARA gene 
[66,70] which contains a highly polymorphic trinucleotide repeat on the first exon. The 
percentage of heterozigosity regarding the number of repeats is extremely high, which 
makes this gene of big interest for this specific study. 100 bp away from this 
polymorphic short tandem repeat (STR) there is a recognition site of an enzyme - HPAII - 
sensitive to methylation. As we know, methylation of specific sites is correlated with 
inactivation in the X. Being the enzyme methylation sensitive it means that if the 
recognition site is methylated the enzyme will not cut. If we are able to distinguish 
between maternal and paternal X, performing a restriction assay with this enzyme can 
inform us which parental chromosome is methylated. We performed an analysis of the 
samples using the HUMARA assay, since our set of SNPs for ATRX and XIST was not 
informative.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allele sizes (bp) 
 
embryo amnion chorion 
umbilical 
cord 
placenta1 placenta2 placenta3 placenta4 placenta5 placenta6 
 Embryo Mother Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp Xm/Xp 
B2 
265 
285 
265 
274 
60,9/ 39,1 77/33 46/54 57,8/42,2 44,5/55,5 57,7/42,3 88/12 - - - 
B4 
281 
278 
281 
270 
42,7/57,3 47,1/52,9 46,8/53,2 40,7/49,3 52,6/47,4 - - - - - 
C1 
279 
281 
279 
270 
38/63 47/53 - 40,7/49,4 52,6/47,5 48,8/51,3 10,3/89,8 66,1/33,9 61,7/38,3 53,2/46,8 
F1 
290 
270 
290 
265 
46,3/53,7 46,4/53,6 39,8/60,2 49,1/50,9 36,4/63,6 45,3/54,7 49,6/50,4 33,3/66,7 - - 
F3 
273 
290 
273 
279 
63,3/36,7 61,9/38,1 65,3/34,7 64,1/35,9 43,2/56,8 63,3/36,7 68,3/31,7 55,3/44,7 - - 
H1 
281 
268 
281 
273 
37,9/62,1 36,5/63,5 32,5/67,5 35,5/64,5 35,3/64,7 43,9/56,1 43,4/56,6 36,9/63,1 -  
L1 
284 
279 
284 
276 
42,2/57,8 - 48,2/51,8 36,1/63,9 36,1/63,9 26,5/73,5 53,3/46,7 58,5/41,5 41,6/58,4 - 
L2 
287 
270 
287 
281 
42,4/57,6 - 40,3/59,7 35/65 25,2/74,8 47,1/52,9 13,6/86,4 42,5/57,5 42,4/57,6 - 
M1 
270 
265 
270 
276 
37,2/62,8 42,6/57,4 42,7/57,2 42,7/57,3 0/100 33,5/66,5 - 48,7/51,3 37,1/62,9 34,5/65,5 
N1 
265 
284 
265 
262 
64,4/35,6 57,8/42,2 61,3/38,7 60,2/39,8 59,6/40,4 46,4/53,6 61,4/38,6 48,8/51,2 68,7/31,3 79,6/20,4 
Table 7: Expression (%) of the Xm and Xp in embryonic and extra-embryonic tissues based on HUMARA 
assay results. The letters of the samples indicates that they were collected at the same time. At grey 
samples that were not collected. At yellow samples with skewing  
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From our initial 14 samples, 10 generated results that we could analyze. These 
samples were all heterozygous for the HUMARA gene as we could see two peaks with 
the GeneMarker software (Figure 8), enabling us to distinguish between the paternal 
and maternal allele in the embryo and extra-embryonic tissues. From those 10, 7 had a 
complete set of extra-embryonic tissues collected and analyzed, and most of them 
(except sample B4) had more than 3 samples of placenta collected. The mean 
expression percentage (calculated using Xp values) when looking through the 
population analyzed (embryonic and extra-embryonic tissues) was 61.5 ± 14.1, this 
indicates that there is some degree of variability between samples. Here we define 
skewing, like other authors, when the allele expression is less than 20% or higher than 
80% concerning or Xm or Xp, otherwise we consider the expression being random. 40% 
of the samples showed at least one tissue sample with skewed expression (placenta 3 
from B2; placenta 3 from C1; placenta 1 from M1 and placenta 6 from N1). From these 4 
skewed samples, two were towards the maternal allele and two towards the paternal, 
corroborating the idea that in previous works the results were biased due a small set of 
samples analyzed. Curiously, in the embryo proper, where we expected to see 50/50 
expression of Xm and Xp, indicating random inactivation, we observe some small 
deviations of the values, and usually this small deviation also occured in the rest of the 
Figure 8: Output from GeneMarker of the complete set of C1 samples. A) Results from the uncut DNA analysis. The 
two peaks correspond to different size alleles from each chromosome. The similar high of the peaks is indicative of 
equal expression from Xm and Xp. B) Results from the DNA after cutting with HPAII analysis. Is visible a higher variation 
between samples than with the DNA, still equal expression is observed, except for placenta3. The arrows represent a 
slight skewing in the tissue. 
A 
B 
C1 
sample 
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tissues always towards the same allele. This could indicate some biased results from the 
assay itself due probably to the size of the alleles. Nevertheless, this small deviation 
does not change significantly the results analysis. Regarding our data, there are strong 
evidences of random inactivation in the placenta samples. 
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IV.2 Dynamics of XCI in the differentiation of human embryonic stem cells 
 
In mice, XCI starts at the X inactivation center and then spreads towards the rest of 
the chromosome. Understanding the expression of X-linked genes along the 
chromosome could help us to understand this issue. We choosed a set of genes that 
covers the entire chromosome (Figure 9A), each one containing a well known and 
described SNP, to study the expression levels during stem cell differentiation. Analyzing 
the SNP expression by sequencing cDNA would also give us some insights about XCI 
direction in stem cells and would help us evaluate and characterize cell lineages 
accordingly to the process itself (random or skewed inactivation). DNA and RNA from 
two cell lineages prior and post differentiation were extracted; a female h2241 and a 
male h2258, both were cultivated and differentiated at the same exact conditions. The 
first step was to genotype the female lineage (h2241) for the SNPs (Figure 9B) and then 
to analyze the allele expression on cDNA before and after differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SYTL4 and GPC4 didn’t give us a good sequence and for that we couldn’t genotype 
the respective SNPs. Of the 9 genes studied, 3 were polymorphic (SUV39H1, XIST and 
IL13RA1). When cDNA from the hESCs, before and after differentiation, was sequenced 
we observed that both alleles for IL13RA1 and SUV39H1 were expressed, meaning that 
or the XCI is random or that it didn’t occur yet or even that the genes were escaping it. It 
was not possible to amplify XIST on the cDNA, so no sequencing results are presented 
for XIST (Figure 9C). The same was observed when qPCR (Figure 10) was performed on 
cDNA of h2241 material, conversely to what we would expect.  
Gene Genotype 
TBL1X GG 
PIGA CC 
ZFX CC 
SUV39H1 AG 
OPHN1 AA 
XIST AG 
ATRX CC 
SYTL4 - 
IL13RA1 TG 
GPC4 - 
G6PD 
CC 
CC 
AA 
Figure 9: Genotype of h2241 for the X-linked genes. A) Representation of X chromosome and the physical 
localization of the genes along the chromosome. B) Table resume of h2241 genotype, at bold the herozygotic 
alleles. C) Sequencing results for the heterozygotic genes, at the top from the genomic DNA, down on the left from 
cDNA at undifferentiated state (D0) and down at right from cDNA at differentiated stage (D7). At yellow the SNP. 
A  B  h2241 gDNA 
h2241 undif cDNA h2241 diff cDNA 
C 
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When analyzing the expression profile of pluripotency markers such as NANOG, 
SOX2, LIN28, OCT4, EZH2 and TDGF2 we can see downregulation on both lineages, 
except for KLF4. SOX2 suffered a higher reduction of expression in h2258 than in the 
female lineage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A  
E  
B C  
D  
Figure 10: Expression analysis of X-linked and pluripotency genes by qPCR. A) Expression of pluripotency genes in 
h2241 and h2258 undifferentiated (undiff) and differentiated (diff) B) Expression of X-linked genes before and after 
differentiation in h2241. C) Expression of X-linked genes before and after differentiation in h2258. D) Comparison of 
the expression of X-linked genes in h2241 undifferentiated with h2258 undifferentiated. E) Comparison of the 
expression of X-linked genes in h2241 differentiated with h2258 differentiated. The expression levels are represented 
as the average fold, and the error bars represent the standard deviation. All data were normalized using two 
housekeeping genes (HARP and GAPDH). 
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Looking at the expression of X-linked genes in h2241 before (D0) and after (D7) 
differentiation we didn’t see high differences in expression levels, except for SYTL4 that 
is upregulated after differentiation and GPC4 that is downregulated. ZFX also gets 
slightly upregulated after differentiation, although this is a well known escapee gene 
[71], meaning that is not silenced in the Xi. In lineage h2258 we also observed 
upregulation after D7 of PIGA, ZFX and SYTL4. When comparing female and male 
lineages we expected to see differences in gene expression on D0 and according to the 
theory about dosage compensation in mammals, at D7, we expect to see approximately 
the same expression levels if the cells were initially XaXa and become XaXi, although we 
need to take into account that these lineages are obviously derived from different 
blastocysts and that we are going to have slight differences due to different genetic 
backgrounds. PIGA, SUV39H1, GPC4 and G6PD seems to behave like we would expect in 
the female lineage if cells were XaXa, having in the undifferentiated state at D0 half fold 
expression when compared to the male cells and after in D7 they present approximately 
the same expression. Looking at each lineage itself we can see that in h2241, there is 
downregulation of SUV39H1, GPC4 and G6PD, while in h2258 PIGA gets upregulated. On 
the other hand, other genes (ATRX, SYTL4 and IL13RA1) present half fold expression in 
h2258 when compared to h2241. Four of the analyzed genes behaved exactly as we 
would expect if the cells were XaXa and became XaXi, other genes seemed to behave 
like if the cells were XaXi, suggesting that the cells could already start differentiating. 
As a high percentage of the X-linked genes in study showed low heterozigosity values 
in the different samples that we analyzed (appendix III), we decided to explore the 
online resources available in order to enlarge our pool of informative genes in study. 
Table 8 summarizes the chosen genes, with the respective primers and SNPs. The next 
step will be to test the primers efficiency for qPCR and to test if we can discriminate 
between the different alleles by sequencing. No available restriction enzymes with a 
recognition site within the SNP were found for these new genes. 
 
 
 
 
 
 
 
 
 
 
 
 Primers    
Distance from 
primers (bp) 
Gene FW RV 
Fragment 
Size (bp) 
SNP Sequence FW FW RV 
PRPS2 CCCCTTCCCTACATCTAGCC GGTCTCCTGGTTGCTGAACT 245 rs1731469 GGACCT(G*/C)TCCCA 146 55 
OATL1 ACCTGCTGAACGTGTATCCAG GTCCATGACAGCGAGGATG 320 rs2293948 AGCGA(A/C/G*)CCCTGA 74 206 
ARMCX3 TGCTTTTTATCTCGCTGCCTA TTTGCCTCCTCTGTGCTCTC 300 rs6995 TTTGTGT(A*/G)TCATCA 97 160 
ZNF75 GGAGACACTAGACATGCTTC AAGGGCTTCTCTCCTGTGTG 181 rs1129093 GCTACA(C*/T)GTATAA 72 86 
IDS TGTATGGCTTGCTCAGTGCT CCGCCTGTACGACTTCAACT 281 rs1803782 GACCA(G*/C)CTATAC 144 136 
MPP1 GAAGAATTCTGGCCACCGTA GCTGTATCGCATCCATTGAA 493 rs2664162 TTCAG(C/A*)GTGATTC 26 426 
Table 8: New X-linked genes: information about the primers and SNPs.  
*indicates the ancestral allele  
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IV.3 Derivation of Human Embryonic Germ Cell lines 
 
Several gonads were collected, when possible, from embryos with 8 to 11 weeks of 
gestation. The gonads (Figure 11A) were trypsinized and maintained in culture using two 
different mediums [72]. After one week in culture, they were screened for colonies 
growth (Figure 11B). Of the eleven sets of human gonads, only one showed colonies 
outgrowth, cultivated in N2B27+LIF+2i medium (or ground state medium) without 
feeders. The gonads were collected from a male embryo with 11 weeks. Colonies were 
split routinely 3 days a week and the cells were morphologically similar to mES cells, 
forming compact colonies with defined borders (Figure 11C). Nevertheless, cells didn’t 
react normally to culture in glass coverslips tending to form spontaneous embryonic 
body-like colonies (Figure 11D). To solve this problem the immunostainings were 
performed directly in 12-well culture plates and visualized using an inverted fluorescent 
microscope.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cells expressed SSEA1, SSEA3 and OCT3/4 heterogenously (Figure 12B) as so 
NANOG and SOX2. However, human specific markers of embryonic germ cells like TRA1-
60 and TRA1-81 were not being expressed by the cells, as we would expect from human 
EG cells. Alkaline phosphatase was also performed and showed positive staining (Figure 
12C).  
To test if cells were clonal, one of the requisites to define pluripotency, cells stained 
with SSEA1, SSEA3, SSEA4 and respective negatives were single-cell FACS sorted into 
a 96 well culture plate. After one week in culture, colonies started to grow (Figure 12C), 
but the fluorescence was lost. Of SSEA1 positive cells, 58% originated colonies as well 
58.3% of the SSEA4 and of the SSEA3 positive cells. On the other hand, from the SSEA1, 
SSEA3 and SSEA4 negative cells 50%, 25% and 58.3% originated colonies, respectively. 
This could mean that all the cells of the population, even if negative to germ cell 
markers, have the ability of clonal expansion. 3 of those colonies were split until they 
adopted the morphological characteristics of the initial cell population, originating 3 
sub-clones of the hEGs, after which they were cryopreserved.   
A B C D 
Figure 11: hEGs culture. A) 17 weeks female gonads freshly isolated before culture B) Colony of hEGs cells after one 
week in culture, N2B27+LIF+2i medium C) hEGs colonies after establishment of the line (passage 8) D) Embryod-
body like structures formed when cultured in glass coverslips. The scales represent 500µm. 
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Figure 12: Evaluating pluripotency. A) Immunostainings for SSEA1, SSEA3 and OCT3/4 B) clonal assay: clonal colony formed after 
15 days in culture from a single cell stained with SSEA1 C) Alkaline-phosphatase staining. The scales represent 500µm 
A 
B 
C 
DAPI SSEA1 MERGE 
DAPI SSEA3 MERGE 
DAPI OCT3/4 MERGE 
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We also repeated the experiment twice with supra-renal or adrenal glands, where 
extra-ectopic PGCs were reported to be localized in mice [73]. Interestingly the cells 
started to form neuron-like colonies constituted by clusters of small cells (Figure 13A). 
These clusters were only observed over other fibroblast-like cells, and as we continued 
to split them and the fibroblasts died, also these clusters disappeared (Figure 13B and 
13C). The clusters were observed both times we set this experiment. As the adrenals 
have neurocrest cells these cell clusters are most probably of neural stem cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our set of experiments was repeated using different combinations of N2B27 medium 
with/without inhibitors in the first days of culture. We observed that starting the culture 
without the inhibitors, and adding those two days after would generate what seems 
colonies of hEGs, but the experiment was not taken forward, as we didn’t have at that 
moment an established feeder-cell line that we could use. 
Figure 13: Culture of supra-renal glands. A) Colonies formed after one week in culture with N2B27+LIF+2i B) 
colonies after one passage C) Colonies after three passages. The scales represent 500µm 
A B C 
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V- Discussion 
 
Unlike in humans, much is known about the X inactivation process in mouse, 
regarding not only to the dynamics itself but also to the molecular aspects of it. 
Understanding XCI is not only important to comprehend important X-linked diseases like 
X-linked Congenital Ataxias, Fragile X Syndrome and Rett syndrome[74] as the complete 
panorama of the kinetics of the process would give us important insights on stem cells 
properties, such as evaluating pluripotency levels. 
Two forms of XCI have been described: paternal X chromosome imprinting in 
marsupial mammals and in the extra-embryonic tissues of mice, rats and bovines, and 
random XCI, in the embryo proper of Eutherian mammals [19]. Much is known about 
the XCI dynamic and kinetics in mice. Nevertheless, we can’t extrapolate the knowledge 
we have about this mechanism directly to humans as it is known that the early steps of 
development occur in different timings in mouse and human embryos, although there is 
some evidence that human XCI follows the same steps as mouse XCI.  
 
Though working with human embryonic material is often quite difficult due to ethical 
restrictions concerning the use of surplus embryos from IVF treatments and other 
difficulties in obtaining permissions and/or recruiting patients many studies have been 
focused in studying term placenta, yet there are still many questions to solve. Although 
some studies [23,24] about XCI in humans have been performed focusing the placenta, 
none of them have reached clear conclusions and there is no consensus about this 
subject. Study the human placenta and other extra-embryonic tissues, as we did along 
this project, through different developmental ages should help to clarify this issue. In 
the moment of collection of the samples, we took into consideration that the placenta is 
constituted both from epiblast and trophoblast derived tissues and that it’s composed 
of patches of cells, facts that could have biased results from other studies. Looking at 
the results from restriction enzymes assay and from the HUMARA assay together, there 
are clear evidences for random X inactivation in the extra-embryonic tissues from the 
first trimester of gestation.  A curious aspect of the results of the HUMARA assay is that 
in the embryo material, where we expected to see around 50/50% of expression on 
both chromosomes, there were some samples with deviations from this proportion, and 
that the deviations occured in the same direction in the different extra-embryonic 
tissues. This could be due to different HUMARA allele sizes that biased the reading in 
the fragment run. The fact that we observed skewing of one placenta sample, in both 
paternal and maternal directions, in 40% of our samples corroborates the idea that 
previous studies had biased results due to a small number of placenta samples analyzed. 
 
Another important question about XCI is if the dynamics of the process occurs 
similarly with what has been described in mice. In the mouse X chromosome, the DNA 
methylation and subsequent gene silencing starts at the Xic and than spreads from this 
location to the rest of the chromosome [27]. If this is true in humans, we would expect 
to see genes physically near the XIC being silenced first and the ones more in the ends of 
the chromosome later. An ideal system to study this turns out to be stem cells 
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differentiation, as they recapitulate XCI in vitro if they are initially XaXa [22]. At the same 
time, studying X inactivation in stem cells can be a powerful tool to characterize 
different lineages according to their pluripotency state. X inactivation occurs gradually 
during ESCs differentiation, and collecting material regularly during this process would 
help answering this. For that we aimed to develop an assay using X-linked genes 
situated along the chromosome to study the different expression levels during 
differentiation by quantitative RT-PCR based on parental allele specific expression, using 
sequencing information.  
We used the material from undifferentiated and differentiated samples of two 
different lineages, a female (h2241) and a male (h2258), not only to evaluate the 
correlation between pluripotency and X inactivation but also to infer about dosage 
compensation and XX status on this material. According to literature, we would expect 
to see, after differentiation, similar expression between the two cell lines concerning 
the X-linked genes due to a decrease on the genes expression in h2241 as a 
consequence of the gene silencing and a slight upregulation on h2258, if the cells were 
initially XaXa. Although great part of the genes behaved as expected (PIGA, SUV39H1, 
GPC4 and G6PD) others did not, and inclusive no XIST expression was observed in h2241 
on D7 of differentiation. We could argue that the cells were not differentiated after the 
seven days, but looking at pluripotency genes expression we observed a downregulation 
of their expression, except for KLF4. This could mean that the XIST primers aren’t proper 
for qPCR. It could also been the case that the cells just started differentiating at D7, and 
no detectable XIST was being expressed. If the cells were indeed XaXi, than the 
dynamics of the inactivation was occurring differently than what has been observed in 
mouse. A way to solve this question would be to perform an RNA-FISH for XIST and 
H3K9 or H3K27 methylation immunostaining. We could also differentiate cells beyond 
seven days and check XIST expression together with the pluripotency factors expression. 
Taking into consideration that the primers could not be suitable for qPCR (although they 
were described) we aimed to develop and properly test new sets of primers for the XIST, 
also evaluating primers already described in literature. The upregulation of KLF4 
observed here could indicate differentiation towards epithelium fates, as this gene is 
expressed in the epithelia of skin, lung, gastrointestinal tract and several other organs 
[75]. On the other hand, this gene is also essential for somatic cell reprogramming (iPS 
cells) [47] and some studies report that KLF4 is required for both mES cell self-renewal 
and maintenance of pluripotency and that the expression of KLF4 prevents mES cell 
differentiation in response to withdrawal of leukemia inhibitory factor (LIF) or bone 
morphogenetic protein 4 (BMP4). Also, KLF4 directly binds to the promoter region of 
NANOG and regulates its expression playing an important role in ES cell self-renewal and 
in preventing ES cell differentiation [76]. Meaning that, on D7, the cells could still be at a 
semi-differentiated state.  We pretend to further extend this analysis using more hESCs 
line, together with iPS lines derived here at the Department of Anatomy and 
Embryology of the LUMC to have more statistically significant results, as these results 
could be due to the genetic background of these particular lines. Besides, it also would 
be of special interest to perform a molecular cytogenetic analysis on the cells.  
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Of the eleven genes that constituted our analysis, h2241 was heterozygotic only for 3 
of them. The sequencing of other samples (in appendix III) also showed low levels of 
heterozygosity. We made use of the online databases available to expand the list of X-
linked genes with characterized SNPs with higher heterozigosity on the European 
population. The next step will be to test the efficiency of the new build primers for 
quantitative RT-PCR and for sequencing. 
 
The high interest in Primordial Germ Cells is due, in part, to the fact that these cells 
undergo X chromosome reactivation and epigenetic reprogramming, including erasure 
of imprintings, during their migration journey to and in the gonads [53]. Understanding 
how reactivation is achieved in these cells would be of extreme interest. The derivation 
of hEG cell lines would also represent a huge innovative breakpoint on the history of 
stem cells research. Several groups [55,58,62,77] have attempted to derive these cells 
from human gonads with ages between 5 to 9 weeks post-conception, always using 
feeders and under poorly defined batches of mediums. In all the reports the efficiency 
rate of derivation was extremely low (between 5 to 14%) and the cells only survived in 
culture, in maximum, one year. The derived hEGs showed expression of pluripotency 
markers, yet they differentiated quite easily, they could not give rise to teratomas in 
mice and they could not be freeze-thawed. With the definition of the ground sate 
medium [60] for mouse-cells feeder-free culture, achieved with additives as small 
molecule inhibitors (PD0325901 and CHIR99021) and LIF, we tried to derive PGCs into 
hEG lines. This derivation has revealed a high risk project, and from the 11 gonads on 
culture, only one gave rise to colonies and was maintained for 6 months in culture. The 
cells expressed SSEA1, SSEA3, SSEA4, OCT3/4 NANOG and SOX2. They were also clonal, 
originating colonies with the same morphology as the original ones, from single-cells in 
culture. However the line was derived from a male embryo, so we couldn’t perform any 
analysis to infer X chromosome inactivation state. We tried to evaluate the methylation 
status of some genes, to infer if the imprints were already completely reversed using 
bissulfite conversion. We did not get any results, not even DNA amplification with 
human specific primers not even with the HUMARA primers. This together with the fact 
that no expression for human specific  pluripotency markers, TRA 1-60 and TRA 1-81 
[78], was detected and that the cells had a morphology and behavior very similar to 
mESCs made us investigate the origin of the cells, as, at that moment, mESCs were also 
cultured using the same medium, cross-contamination was a possibility. The cells were 
proved to be of mouse origin. We also developed a set of experiments where we tried 
different combinations of N2B27 medium with/without inhibitors in culture and we 
observed that when the culture is started only with N2B27 and adding the inhibitors two 
days after, some colonies start to growth, although we could not continue the 
experiment as no feeder-cell line was being cultured at the moment. 
We want to continue these experiments using not only the gonads but also the supra 
renal glands, as ectopic PGCs have been observed localized nearby these glands [73]. 
We tried already twice establishing culture from this tissue, yet we observed the 
growing of neuron-like cluster of cells, which is not a total surprise, as the medium, 
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N2B27+LIF+2i, without the addictives has been used in the derivation of neuronal stem 
cells [77].  
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VI – Final Remarks 
 
With this work we were able to reach important conclusions about the XCI form in 
human extra-embryonic tissues. The future step in understanding the inactivation 
kinetics and dynamics in humans would be to use surplus blastocysts from IVF 
treatments to ascertain at what stages does the random inactivation occurs and what 
exactly are the steps behind it.  
The connection between XCI and pluripotency in stem cells has also a highly potential 
value to characterize cell lines capacity for differentiation and their future clinical 
applications. With the development of a SNPs analysis set for specific allele expression 
along the X chromosome in this work, we can easily characterize stem cell lines 
accordingly to their XCI status. It would be of extreme interest to perform an identical 
analysis to other hESC lines and iPS cell lines to enlarge our information about the 
specificities of XCI in culture conditions.  
Finally, the derivation of hEG lines under chemically defined conditions and without 
the need of feeders would represent not only an important outbreak in stem cells 
research but also a tool to better understand the process behind XCI in humans. 
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Appendix I- Information about the embryos material collected 
 
 
 Sex Age Embryo Mother Chorion 
Umbilical 
Cord 
Amnion Pla1 Pla2 Plac3 Pla4 Pla5 Pla6 Pla7 Pla8 Pla9 Pla10 Pla11 Pla12 
A1 male 
5-6 
weeks 
+ + + + + + - - - - - - - - - -- -- 
A2 female ND + + + - + + - - - - - - - - - - - 
A3 female ND + + - - - + - - - - - - - - - - - 
A4 male 
10 
weeks 
+ + + + + + - - - - - - - - - - - 
A5 female 
4-5 
weeks 
+ + - - - + - - - - - - - - - - - 
B1 female 6w3 + + + - - + - - - - - - - - - - - 
B2 female 9w5 + + + + + + + + + - - - - - - - - 
B3 female 8w5 + + + + + + - - - - - - - - - - - 
B4 female 7w3 + + + + + + - - - - - - - - - - - 
C1 female 12w0 + + + + + + + + + + + - - - - - - 
C2 male 6w0 + - - - - - - - - - - - - - - - - 
C3 male 12w3 + - - - - - - - - - - - - - - - - 
D1 female ND + + - - + + - - - - - - - - - - - 
D2 male ND + + - - + + - - - - - - - - - - - 
E1 male 8w1 + + - - + + + + + + + - - - - - - 
E2 male 7w1 + + - - + + + + + - - - - - - - - 
E3 female 6w1 + + - - - - - - - - - - - - - - - 
F1 female 7w5 + + + + + + + + + - - - - - - - - 
F2 female 8w5 + + + + + + + + + - - - - - - - - 
F3 female 6w6 + + + + + + + + + - - - - - - - - 
G1 male ND + + - - + + + + + - - - - - - - - 
H1 female 8w6 + + + + + + + + + - - - - - - - - 
I1 male 7w3 + + - - - - - - - - - - - - - - - 
I2 male 7w4 + + - - - - - - - - - - - - - - - 
I3 female 11w4 + + + + + + + + + + + + + + + + + 
J1 male 8w5 + + - - - - - - - - - - - - - - - 
 B 
 
J2 male 10w5 + + - - - - - - - - - - - - - - - 
J3 female 9w3 + + - - - - - - - - - - - - - - - 
K1 male 9w0 + + - - - - - - - - - - - - - - - 
K2 male 7w6 + + - - - - - - - - - - - - - - - 
L1 female 8w1 + + + + + + + + + + - - - - - - - 
L2 female 8w + + + + - + + + + + - - - - - - - 
M1 female 8w4 + + + + + + + + + + + - - - - - - 
N1 female 8w1 + + + + + + + + + + + - - - - - - 
N2 female 10w4 + + + + + + + + + + + - - - - - - 
O1 male 10w4 + + + + + + + + + + + - - - - - - 
P1 female 8w4 + + + + + + + + + + + - - - - - - 
P2 male 8w5 + + + + + + + + + + + - - - - - - 
Q1 male 9w0 + + + + + + + + + + + - - - - - - 
R1 female 12w0 + + + + + + + + + + + - - - - - - 
R2 male 9w1 + + + + + + + + + + + - - - - - - 
S1 female 9w3 + + + + + + + + + + + - - - - - - 
S2 female 8w5 + + + + + + + + + + + - - - - - - 
S3 male 9w1 + + - - - - - - - - - - - - - - - 
T1 female 11w0 + + + + + + + + + + + - - - - - - 
T2 female 9w4 + + + + + + + + + + + - - - - - - 
U1 male 8w4 + + + + + + + + + + + - - - - - - 
U3 male 9w1 + + + + + + + + + + + - - - - - - 
V1 male 12w0 + + + + + + + + + + + - - - - - - 
W1 male 12w4 + + - - - - - - - - - - - - - - - 
W2 female 8w4 + + - - - - - - - - - - - - - - - 
X2 female 9wk0 + + - - - - - - - - - - - - - - - 
Y1 male 7w2 + + - - - - - - - - - - - - - - - 
Z3 male 9w3 + + - - - - - - - - - - - - - - - 
AA2 male 9wk6 + + - - - + + + + + + + + - - - - 
AB2 male 11wk0 + + - - - + + + + + + + + - - - - 
AC1 male 11wk0 + + - - - - - - - - - - - - - - - 
ND not defined 
+ samples collected 
- no sample collected  
Pla - placenta 
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Appendix II – Information about primers 
 
 Primers   Distance from primer (bp)  
Gene FW RV Fragment Size (bp) SNP FW RV Sequence FW 
TBL1X GACACCATCTCTACCCCAC TGCTTGCGACACATCCCA 146 rs7256 63 48 TTAGG(G/A*)CATGG 
PIGA AGGTTTTAGAGGCATGCCAC CGACCAGTGCAAACTGACAG 254 rs3087965 140 116 GATTTG(A*/T)AAATT 
ZFX TGGCAAACCTCTGAAGTGCT ACATTATGGGGGCCAAGAAG 157 rs5949242 102 15 CTTA(C/T*)AGGA 
SUV39H1 TTGTGCTCACCCTGGTTC GCATAGGGTTGAGGGGTGTA 291 rs3373 205 49 CCGCCG(A/G*)CCCCCC 
OPHN1 GCAAACTGGGCTGGAAGATA GGATGTCACCAGTCTCTTAG 250 rs492933 109 101 TGGCA(C/T*)TTGTTA 
XIST CAGCATGGTTGGTGACACCTAAG TGGAATGAGCAGTGTGCGAT 240 rs1894271 154 45 CACA(A*/G)TTGT 
ATRX TGGTTTTGAGATGCTTGCTC CAGCAGAAGGCACAGTTGAT 185 rs3088074 97 50 AAACTCT(G/C*)AGAGTTT 
SYTL4 ATGAACCGAATGGAGGAATG ATTAAAGCACACATACATGTCAG 135 rs8780 139 2 ACCCC(G*/C)CTGACA 
IL13RA1 TGATGACAACTACAGAAAAACC AGACTGTAAACCCCTGGAAG 235 rs2254672 38 157 GCCATT(G*/T)TAGGC 
GPC4 ACCTGTTTGCAGTGACAGGA CACGTCGTTCCCATTGTATG 157 rs1048369 11 76 TGGTTG(G*/A)CTAATCC 
G6PD 
   rs72554664 83 96 CGCCTA(C*/T)GAGCG 
GATGATGACCAAGAAGCCGG TTCTCCAGCTCAATCTGGTG 218 rs72554665 151 21 CCTGG(C*/A/G)GTATTTT 
   rs2230037 160 11 TTTTC(G*/A)CCCCA 
Table :  X-linked genes: information about the primers [20] and SNPs  
*indicates the ancestral allele  
 D 
 
 
 
 
 
Gene Fw primer  Rv primer 
OCT3/4 CCTGTCTCCGTCACCACTCT CAAAAACCCTGGCACAAACT 
SOX2 CACCTACAGCATGTCCTACTCG GGTTTTCTCCATGCTGTTTCTT 
NANOG TACCTCAGCCTCCAGCAGAT TGCGTCACACCATTGCTATT 
ZFP42 TGGAGCCTGTGTGAACAGAA TGTGCCCTTCTTGAAGGTTT 
LIN28 AAGCGCAGATCAAAAGGAGA CTGATGCTCTGGCAGAAGTG 
GDF3 CGGGAATGTACTTCGCTTTC CCCTTTCTTTGATGGCAGAC 
TDGF1 CCCAAGAAGTGTTCCCTGTG TGCAGACGGTGGTAGTTCTG 
KLF4 GATGGGGTCTGTGACTGGAT CCCCCAACTCACGGATATAA 
EZH2 CCTGTGCACATCCTGACTTC TGGGATGACTTGTGTTGGAA 
 
  
Table :  Quantitative RT-PCR primers [69] for pluripotency genes 
 E 
 
Appendix III – Genotyping of X-linked genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  DNA DNA DNA DNA 
Gene SNP F2 mom 2241 hES 243 hiPS W2 emb 
TBL1X rs7256 - GG GG - 
PIGA rs3087965 CC CC CC CC 
ZFX rs5949242 CT CC CT CC 
SUV39H1 rs3373 AG AG - GG 
OPHN1 rs492933 AG AA AG AG 
XIST rs1894271 AG AG AA AA 
ATRX rs3088074 CT CC CC CT 
SYTL4 rs8780 - - - - 
IL13RA1 rs2254672 NS TG - GG 
GPC4 rs1048369 NS - CC CC 
G6PD 
 NS CC CC CC 
rs2230037 NS CC CC CC 
 NS AA AA AA 
Table : Genotyping of diferente samples for X-linked genes 
- didn’t gave a good sequencing result 
NS not sequenced 
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Appendix IV – Buffers, Solutions and Culture Mediums 
 
 
 
1x PBS: 
- NaCl 137 mM 
- KCl 2.7 mM 
- Na2HPO4 10 mM 
- KH2PO4 2 mM 
(Adjust pH to 7.4 with HCl) 
 
1xTAE 
- EDTA (pH8) 1mM 
- Acetic acid 20mM 
- Tris base 40mM 
 
Proteanase K Lysis Buffer: 
- 50 mM Tris, pH 8.0 10 mM Tris, pH 8.0 
- 100 mM EDTA 0.1 mM EDTA 
- 100mM NaCl 
- 1% SDS 
 
Medium DMEM 7.5%: 
- DMEM with HEPES (Gibco) 
- 5 mL MEM Non-Essential Amino Acids Solution 10 mM (100X) (Gibco) 
- 1 mL 2-mecaptoethanol (0,1 mM) (Gibco) 
- 2,5 mL Pen/Strep (0,5%) (Gibco) 
- 7.5 % FCS (Gibco) 
 
Medium N2B27: 
- 240 mL Dmem F12 (11320 Invitrogen) + 240mL Neurobasal ® (Gibco) 
- 5 mL N-2® supplement (100x) (Invitrogen) 
- 10 mL B-27® Serum-Free Supplement (50X) (Invitrogen) 
- 5 mL MEM Non-Essential Amino Acids Solution 10 mM (100X) (Gibco) 
- 1 mL 2-mecaptoethanol (0,1 mM) (Gibco) 
- 2,5 mL Pen/Strep (0,5%) (Gibco) 
- 33,3 mL Bovine Albumin Fraction V Solution (7.5%) (Invitrogen) 
Supplements (N2B27+LIF+2i): 
- 12,5 µL 4mM PD0325901 (final: 1 µM) (Axon) 
- 37,5 µL 4mM CHIR99021 (final: 3 µM) (Axon) 
- 100 µL mrLIF (1200U/mL; ESGRO; Chemicon) 
 
 
 G 
 
Medium EG: 
-  Dmem F12 (11320 Invitrogen) 
- 15 % FCS (Gibco) 
- 0.1% MEM Non-Essential Amino Acids Solution 10 mM (100X) (Gibco) 
- 4 mM Glutamate (Gibco) 
- 0.1 mM 2-mecaptoethanol (0,1 mM) (Gibco) 
Supplements (EG+LIF+FGF) 
-  4 mM   bFGF (25 ng/ml; Invitrogen) 
- 100 µL mrLIF (1200U/mL; ESGRO; Chemicon) 
 
 
Freezing medium: 
- 3 mL of correspodent culture medium 
- 1mL FCS (Gibco) 
- 1mL DMSO (Sigma-Aldrich) 
 
 
0,1 % gelatine in H2O: 
- dissolve 0,5 gram Gelatin from porcine skin (G1890 -Type A; Sigma-Aldrich) with 30 mL 
H2O from 500mL flask (Gibco) 
- place lid loose on tube and tape the tube for the autoclave 
- 30 to 45 minutes in autoclave 
- dissolve the 30 mL in the 500mL flask 
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Appendix V – Quantitative RT-PCR  
 
 Mean Ct Standard 
Deviation 
2241UNDIF <> IL13RA1 27,74667 0,049329 
2241DIFF <> IL13RA1 27,54 0,091652 
2258UNDIF <> IL13RA1 30,04333 0,094516 
2258DIFF <> IL13RA1 27,91 0,175784 
2241UNDIF <> SUV39H1 28,24667 0,090738 
2241DIFF <> SUV39H1 28,47333 0,035119 
2258UNDIF <> SUV39H1 30,12 0,065574 
2258DIFF <> SUV39H1 28,075 0,035355 
2241UNDIF <> SYTL4 32,74 0,37027 
2241DIFF <> SYTL4 30,83667 0,064291 
2258UNDIF <> SYTL4 33,50667 0,477214 
2258DIFF <> SYTL4 30,86 0,087178 
2241UNDIF <> ZFX 32,19 0,137477 
2241DIFF <> ZFX 31,41333 0,051316 
2258UNDIF <> ZFX 34,50333 0,136137 
2258DIFF <> ZFX 31,96333 0,083267 
2241DIFF <> OPHN1 29,89333 0,092916 
2241UNDIF <> OPHN1 30,09 0,208087 
2258DIFF <> OPHN1 29,11333 0,094516 
2258UNDIFF <> OPHN1 31,57667 0,251661 
2241DIFF <> XIST 0,0000 0,0000 
2241UNDIF <> XIST 0,0000 0,0000 
2258DIFF <> XIST 0,0000 0,0000 
2258UNDIFF <> XIST 0,0000 0,0000 
2241DIFF <> ATRX 25,91333 0,105987 
2241UNDIF <> ATRX 25,68333 0,035119 
2258DIFF <> ATRX 25,96333 0,040415 
2258UNDIF <> ATRX 27,225 0,148492 
2241diff <> PIGA 27,75 0,13 
2258diff <> PIGA 27,24667 0,083267 
2258undif <> PIGA 29,88 0,112694 
2241 undif <> TBL1X 26,61333 0,066583 
2241diff <> TBL1X 26,65333 0,122202 
2258diff <> TBL1X 26,01333 0,076376 
2258undif <> TBL1X 27,61 0,18735 
2241DIFF <> G6PD 25,96333 0,075056 
2241UNDIF <> G6PD 25,80667 0,040415 
2258DIFF <> G6PD 25,37 0,065574 
2258UNDIFF <> G6PD 27,97 0,070711 
2241DIFF <> GPC4 23,95667 0,065064 
2241UNDIF <> GPC4 22,54667 0,167432 
2258DIFF <> GPC4 23,34 0,045826 
2258UNDIFF <> GPC4 24,46667 0,187705 
 
 Mean Ct 
Standard 
Deviation 
2241DIFF <> EZH2 29,73333 0,092376 
2241UNDIF <> EZH2 29,00333 0,049329 
2258DIFF <> EZH2 28,58 0,052915 
2258UNDIFF <> EZH2 29,1 0,070711 
2241UNDI <> LIN28 22,80333 0,035119 
2241DIFF <> LIN28 23,54 0,088882 
2258UNDIF <> LIN28 23,34333 0,159478 
2258DIFF <> LIN28 22,38667 0,050332 
2241UNDI <> TDGF1 22,51333 0,051316 
2241DIFF <> TDGF1 23,27 0,081854 
2258UNDIF <> TDGF1 23,61667 0,089629 
2258DIFF <> TDGF1 21,945 0,06364 
2241UNDI <> ZFP42 24,48333 0,025166 
2241DIFF <> ZFP42 24,56333 0,080829 
2258UNDIF <> ZFP42 25,36667 0,040415 
2258DIFF <> ZFP42 23,84 0,042426 
2241DIFF <> KLF4 27,71667 0,068069 
2241UNDIF <> KLF4 28,95 0,095394 
2258DIFF <> KLF4 28,15 0,043589 
2258UNDIFF <> KLF4 31,085 0,148492 
2241undif <> Nanog 22,88667 0,087369 
2241diff <> Nanog 23,61667 0,050332 
2258undif <> Nanog 24,86333 0,049329 
2258diff <> Nanog 23,43667 0,070238 
2241undif <> Oct4 22,34333 0,049329 
2241diff <> Oct4 23,15 0,03 
2258undif <> Oct4 23,68667 0,011547 
2258diff <> Oct4 22,15333 0,138684 
2241undif <> Sox2 26,74667 0,188768 
2241diff <> Sox2 27,61667 0,266896 
2258undif <> Sox2 27,61667 0,061101 
2258diff <> Sox2 24,59333 0,058595 
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